Ranking · Research
Publications, last 5 years
PubMed records matching the cancer’s MeSH-anchored query (stored verbatim with the count) with a publication date in the last 5 full years plus the current year.
Computedci-pubs-5y-v1unit: counthigher = betterAll metrics
| Rank | Δ | Cancer | Publications, last 5 years (count) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Conventional Osteosarcoma | 339,751 | 100 | Medium confidence | pubmed | inputs
ranking row 2584696 |
| 2 | = | Gastric Mixed Adenocarcinoma | 239,003 | 100 | Medium confidence | pubmed | inputs
ranking row 2584697 |
| 3 | = | Carcinoma | 142,030 | 99.9 | Medium confidence | pubmed | inputs
ranking row 2584698 |
| 4 | = | Breast Carcinoma | 134,009 | 99.9 | Medium confidence | pubmed | inputs
ranking row 2584699 |
| 5 | = | Malignant Breast Neoplasm | 133,010 | 99.9 | Medium confidence | pubmed | inputs
ranking row 2584700 |
| 6 | = | Childhood Breast Carcinoma | 131,820 | 99.8 | Medium confidence | pubmed | inputs
ranking row 2584701 |
| 7 | = | Gastric Intestinal-Type Adenocarcinoma | 111,621 | 99.8 | Medium confidence | pubmed | inputs
ranking row 2584702 |
| 8 | = | Lung Carcinoma | 94,693 | 99.8 | Medium confidence | pubmed | inputs
ranking row 2584703 |
| 9 | = | Adenocarcinoma | 93,894 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2584704 |
| 10 | = | Malignant Lung Neoplasm | 93,034 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2584705 |
| 11 | = | Colorectal Carcinoma | 66,754 | 99.7 | Medium confidence | pubmed | inputs
ranking row 2584706 |
| 12 | = | Primitive Neuroectodermal Tumor | 66,748 | 99.6 | Medium confidence | pubmed | inputs
ranking row 2584707 |
| 13 | = | Malignant Colorectal Neoplasm | 65,243 | 99.6 | Medium confidence | pubmed | inputs
ranking row 2584708 |
| 14 | = | Prostate Carcinoma | 52,147 | 99.5 | Medium confidence | pubmed | inputs
ranking row 2584709 |
| 15 | = | Malignant Prostate Neoplasm | 52,116 | 99.5 | Medium confidence | pubmed | inputs
ranking row 2584710 |
| 16 | = | Gastric Diffuse Adenocarcinoma | 48,774 | 99.5 | Medium confidence | pubmed | inputs
ranking row 2584711 |
| 17 | = | Endemic Burkitt Lymphoma | 39,028 | 99.4 | Medium confidence | pubmed | inputs
ranking row 2584712 |
| 18 | = | Gastric Carcinoma | 35,168 | 99.4 | Medium confidence | pubmed | inputs
ranking row 2584713 |
| 19 | = | Malignant Gastric Neoplasm | 34,783 | 99.4 | Medium confidence | pubmed | inputs
ranking row 2584714 |
| 20 | = | Leukemia | 31,893 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2584715 |
| 21 | = | Hepatocellular Carcinoma | 31,541 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2584716 |
| 22 | = | Differentiating Neuroblastoma | 29,851 | 99.3 | Medium confidence | pubmed | inputs
ranking row 2584717 |
| 23 | = | Bronchogenic Carcinoma | 29,489 | 99.2 | Medium confidence | pubmed | inputs
ranking row 2584718 |
| 24 | = | Grade 3 Follicular Lymphoma | 29,046 | 99.2 | Medium confidence | pubmed | inputs
ranking row 2584719 |
| 25 | = | Squamous Cell Carcinoma | 27,413 | 99.2 | Medium confidence | pubmed | inputs
ranking row 2584720 |
| 26 | = | Cervical Carcinoma | 27,302 | 99.1 | Medium confidence | pubmed | inputs
ranking row 2584721 |
| 27 | = | Lung Non-Small Cell Carcinoma | 26,886 | 99.1 | Medium confidence | pubmed | inputs
ranking row 2584722 |
| 28 | = | Malignant Cervical Neoplasm | 26,673 | 99.1 | Medium confidence | pubmed | inputs
ranking row 2584723 |
| 29 | = | Splenic Hodgkin Lymphoma | 26,526 | 99 | Medium confidence | pubmed | inputs
ranking row 2584724 |
| 30 | = | Pancreatic Carcinoma | 26,375 | 99 | Medium confidence | pubmed | inputs
ranking row 2584725 |
| 31 | = | Malignant Ovarian Neoplasm | 25,793 | 99 | Medium confidence | pubmed | inputs
ranking row 2584726 |
| 32 | = | Malignant Pancreatic Neoplasm | 25,767 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2584727 |
| 33 | = | Adult Glioblastoma | 24,612 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2584729 |
| 33 | = | Childhood Glioblastoma | 24,612 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2584730 |
| 33 | = | Glioblastoma | 24,612 | 98.9 | Medium confidence | pubmed | inputs
ranking row 2584728 |
| 36 | = | Lymphoma | 23,070 | 98.8 | Medium confidence | pubmed | inputs
ranking row 2584731 |
| 37 | = | Melanoma | 20,490 | 98.7 | Medium confidence | pubmed | inputs
ranking row 2584732 |
| 38 | = | Thyroid Gland Carcinoma | 19,458 | 98.7 | Medium confidence | pubmed | inputs
ranking row 2584733 |
| 39 | = | Colon Carcinoma | 19,189 | 98.7 | Medium confidence | pubmed | inputs
ranking row 2584734 |
| 40 | = | Bladder Carcinoma | 18,823 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2584735 |
| 41 | = | Sarcoma | 18,818 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2584736 |
| 42 | = | Malignant Colon Neoplasm | 18,406 | 98.6 | Medium confidence | pubmed | inputs
ranking row 2584737 |
| 43 | = | Malignant Bladder Neoplasm | 18,250 | 98.5 | Medium confidence | pubmed | inputs
ranking row 2584738 |
| 44 | = | B-Cell Non-Hodgkin Lymphoma | 18,128 | 98.5 | Medium confidence | pubmed | inputs
ranking row 2584739 |
| 45 | = | Childhood Bladder Carcinoma | 18,063 | 98.5 | Medium confidence | pubmed | inputs
ranking row 2584740 |
| 46 | = | Malignant Liver Neoplasm | 17,939 | 98.4 | Medium confidence | pubmed | inputs
ranking row 2584741 |
| 47 | = | Adult Liver Carcinoma | 17,764 | 98.4 | Medium confidence | pubmed | inputs
ranking row 2584742 |
| 48 | = | B-Cell Malignant Neoplasm | 17,686 | 98.4 | Medium confidence | pubmed | inputs
ranking row 2584743 |
| 49 | = | Myeloid Leukemia | 17,285 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2584744 |
| 50 | = | Non-Hodgkin Lymphoma | 17,190 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2584745 |
| 51 | = | Malignant Head and Neck Neoplasm | 14,779 | 98.3 | Medium confidence | pubmed | inputs
ranking row 2584746 |
| 52 | = | Malignant Neck Neoplasm | 14,717 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2584747 |
| 53 | = | Grade 2 Follicular Lymphoma | 14,169 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2584748 |
| 54 | = | Acute Myeloid Leukemia | 13,980 | 98.2 | Medium confidence | pubmed | inputs
ranking row 2584749 |
| 55 | = | Malignant Thyroid Gland Neoplasm | 13,792 | 98.1 | Medium confidence | pubmed | inputs
ranking row 2584750 |
| 56 | = | Pancreatic Ductal Adenocarcinoma | 13,355 | 98.1 | Medium confidence | pubmed | inputs
ranking row 2584751 |
| 57 | = | Rectal Carcinoma | 12,706 | 98.1 | Medium confidence | pubmed | inputs
ranking row 2584752 |
| 58 | = | Malignant Rectal Neoplasm | 12,506 | 98 | Medium confidence | pubmed | inputs
ranking row 2584753 |
| 59 | = | Childhood Rectal Carcinoma | 12,376 | 98 | Medium confidence | pubmed | inputs
ranking row 2584754 |
| 60 | = | Endometrial Carcinoma | 12,216 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2584755 |
| 61 | = | Esophageal Carcinoma | 12,158 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2584756 |
| 61 | = | Grade 1 Follicular Lymphoma | 12,158 | 97.9 | Medium confidence | pubmed | inputs
ranking row 2584757 |
| 63 | = | Childhood Acute Myeloid Leukemia | 11,700 | 97.8 | Medium confidence | pubmed | inputs
ranking row 2584758 |
| 64 | = | Lymphoid Leukemia | 11,687 | 97.8 | Medium confidence | pubmed | inputs
ranking row 2584759 |
| 65 | = | Malignant Skin Neoplasm | 11,654 | 97.8 | Medium confidence | pubmed | inputs
ranking row 2584760 |
| 66 | = | Adult Acute Myeloid Leukemia | 11,576 | 97.7 | Medium confidence | pubmed | inputs
ranking row 2584761 |
| 67 | = | Renal Cell Carcinoma | 11,049 | 97.7 | Medium confidence | pubmed | inputs
ranking row 2584762 |
| 68 | = | Malignant Esophageal Neoplasm | 10,921 | 97.7 | Medium confidence | pubmed | inputs
ranking row 2584763 |
| 69 | = | Childhood Esophageal Carcinoma | 10,797 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2584764 |
| 70 | = | Adult Hodgkin Lymphoma | 10,617 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2584765 |
| 71 | = | Childhood Hodgkin Lymphoma | 10,578 | 97.6 | Medium confidence | pubmed | inputs
ranking row 2584766 |
| 72 | = | Malignant Endometrial Neoplasm | 10,293 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2584767 |
| 73 | = | Multiple Myeloma | 10,244 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2584768 |
| 74 | = | Diffuse Large B-Cell Lymphoma | 9,818 | 97.5 | Medium confidence | pubmed | inputs
ranking row 2584769 |
| 75 | = | Triple-Negative Breast Carcinoma | 9,775 | 97.4 | Medium confidence | pubmed | inputs
ranking row 2584770 |
| 76 | = | Childhood Osteosarcoma | 9,763 | 97.4 | Medium confidence | pubmed | inputs
ranking row 2584771 |
| 77 | = | Amyloidosis | 9,761 | 97.4 | Medium confidence | pubmed | inputs
ranking row 2584772 |
| 78 | = | Breast Ductal Carcinoma | 9,422 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2584773 |
| 79 | = | Adult Diffuse Large B-Cell Lymphoma | 9,267 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2584774 |
| 79 | = | Childhood Diffuse Large B-Cell Lymphoma | 9,267 | 97.3 | Medium confidence | pubmed | inputs
ranking row 2584775 |
| 81 | = | Head and Neck Squamous Cell Carcinoma | 9,035 | 97.2 | Medium confidence | pubmed | inputs
ranking row 2584776 |
| 82 | = | Childhood Neuroblastoma | 8,746 | 97.2 | Medium confidence | pubmed | inputs
ranking row 2584777 |
| 83 | = | Undifferentiated Neuroblastoma | 8,335 | 97.1 | Medium confidence | pubmed | inputs
ranking row 2584778 |
| 84 | = | Lip and Oral Cavity Carcinoma | 8,294 | 97.1 | Medium confidence | pubmed | inputs
ranking row 2584779 |
| 85 | = | Malignant Lip and Oral Cavity Neoplasm | 8,195 | 97.1 | Medium confidence | pubmed | inputs
ranking row 2584780 |
| 86 | = | Lung Adenocarcinoma | 7,869 | 97 | Medium confidence | pubmed | inputs
ranking row 2584781 |
| 87 | = | Urothelial Carcinoma | 7,491 | 97 | Medium confidence | pubmed | inputs
ranking row 2584782 |
| 88 | = | Oral Cavity Squamous Cell Carcinoma | 7,490 | 97 | Medium confidence | pubmed | inputs
ranking row 2584783 |
| 89 | = | Clear Cell Renal Cell Carcinoma | 7,480 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2584784 |
| 90 | = | Childhood Malignant Neoplasm | 7,329 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2584785 |
| 91 | = | Acute Lymphoblastic Leukemia | 7,302 | 96.9 | Medium confidence | pubmed | inputs
ranking row 2584786 |
| 92 | = | Childhood Non-Hodgkin Lymphoma | 6,640 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2584787 |
| 93 | = | Adult Non-Hodgkin Lymphoma | 6,638 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2584788 |
| 94 | = | Myeloproliferative Neoplasm | 6,431 | 96.8 | Medium confidence | pubmed | inputs
ranking row 2584789 |
| 95 | = | Castration-Resistant Prostate Carcinoma | 6,211 | 96.7 | Medium confidence | pubmed | inputs
ranking row 2584790 |
| 96 | = | Extrapulmonary Small Cell Neuroendocrine Carcinoma | 5,942 | 96.7 | Medium confidence | pubmed | inputs
ranking row 2584791 |
| 97 | = | Osteosarcoma | 5,767 | 96.7 | Medium confidence | pubmed | inputs
ranking row 2584792 |
| 98 | = | Poorly Differentiated Neuroblastoma | 5,259 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2584793 |
| 99 | = | Cholangiocarcinoma | 5,024 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2584794 |
| 100 | = | Esophageal Squamous Cell Carcinoma | 4,844 | 96.6 | Medium confidence | pubmed | inputs
ranking row 2584795 |
| 101 | = | Peripheral Primitive Neuroectodermal Tumor | 4,723 | 96.5 | Medium confidence | pubmed | inputs
ranking row 2584796 |
| 102 | = | Kidney Carcinoma | 4,692 | 96.5 | Medium confidence | pubmed | inputs
ranking row 2584797 |
| 103 | = | Childhood Myelodysplastic Syndrome | 4,676 | 96.4 | Medium confidence | pubmed | inputs
ranking row 2584798 |
| 104 | = | Skin Basal Cell Carcinoma | 4,634 | 96.4 | Medium confidence | pubmed | inputs
ranking row 2584799 |
| 105 | = | Neuroblastoma | 4,633 | 96.4 | Medium confidence | pubmed | inputs
ranking row 2584800 |
| 106 | = | Childhood Acute Lymphoblastic Leukemia | 4,561 | 96.3 | Medium confidence | pubmed | inputs
ranking row 2584801 |
| 107 | = | Gastric Adenocarcinoma | 4,534 | 96.3 | Medium confidence | pubmed | inputs
ranking row 2584802 |
| 108 | = | Cutaneous Melanoma | 4,407 | 96.3 | Medium confidence | pubmed | inputs
ranking row 2584803 |
| 109 | = | Myelodysplastic Syndrome | 4,384 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2584804 |
| 110 | = | Adult Acute Lymphoblastic Leukemia | 4,309 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2584805 |
| 111 | = | Mediastinal Hodgkin Lymphoma | 4,171 | 96.2 | Medium confidence | pubmed | inputs
ranking row 2584806 |
| 112 | = | T-Cell Non-Hodgkin Lymphoma | 4,155 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2584807 |
| 113 | = | Papillary Adenocarcinoma | 4,139 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2584808 |
| 114 | = | Malignant Brain Neoplasm | 4,092 | 96.1 | Medium confidence | pubmed | inputs
ranking row 2584809 |
| 115 | = | Transitional Cell Carcinoma | 4,089 | 96 | Medium confidence | pubmed | inputs
ranking row 2584810 |
| 116 | = | Soft Tissue Sarcoma | 3,995 | 96 | Medium confidence | pubmed | inputs
ranking row 2584811 |
| 117 | = | Thyroid Gland Papillary Carcinoma | 3,993 | 96 | Medium confidence | pubmed | inputs
ranking row 2584812 |
| 118 | = | Adult Soft Tissue Sarcoma | 3,958 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2584813 |
| 118 | = | Childhood Soft Tissue Sarcoma | 3,958 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2584814 |
| 120 | = | Lung Squamous Cell Carcinoma | 3,927 | 95.9 | Medium confidence | pubmed | inputs
ranking row 2584815 |
| 121 | = | Pancreatic Adenocarcinoma | 3,913 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2584816 |
| 122 | = | Intrahepatic Cholangiocarcinoma | 3,903 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2584817 |
| 123 | = | Brain Stem Glioblastoma | 3,855 | 95.8 | Medium confidence | pubmed | inputs
ranking row 2584818 |
| 124 | = | Ovarian Carcinoma | 3,834 | 95.7 | Medium confidence | pubmed | inputs
ranking row 2584819 |
| 125 | = | Malignant Digestive System Neoplasm | 3,816 | 95.7 | Medium confidence | pubmed | inputs
ranking row 2584820 |
| 126 | = | Adult Myelodysplastic Syndrome | 3,789 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2584821 |
| 127 | = | Malignant Kidney Neoplasm | 3,700 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2584822 |
| 128 | = | Nasopharyngeal Carcinoma | 3,621 | 95.6 | Medium confidence | pubmed | inputs
ranking row 2584823 |
| 129 | = | Chronic Lymphocytic Leukemia | 3,554 | 95.5 | Medium confidence | pubmed | inputs
ranking row 2584824 |
| 130 | = | Invasive Breast Carcinoma | 3,504 | 95.5 | Medium confidence | pubmed | inputs
ranking row 2584825 |
| 131 | = | Ovarian Serous Adenocarcinoma | 3,454 | 95.5 | Medium confidence | pubmed | inputs
ranking row 2584826 |
| 132 | = | Acute Leukemia | 3,371 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2584827 |
| 133 | = | Neuroendocrine Carcinoma | 3,283 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2584828 |
| 134 | = | Lung Small Cell Carcinoma | 3,148 | 95.4 | Medium confidence | pubmed | inputs
ranking row 2584829 |
| 135 | = | Malignant Glioma | 3,033 | 95.3 | Medium confidence | pubmed | inputs
ranking row 2584830 |
| 136 | = | Breast Ductal Carcinoma In Situ | 2,951 | 95.3 | Medium confidence | pubmed | inputs
ranking row 2584831 |
| 137 | = | Second Primary Malignant Neoplasm | 2,907 | 95.3 | Medium confidence | pubmed | inputs
ranking row 2584832 |
| 138 | = | Skin Carcinoma | 2,868 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2584833 |
| 139 | = | Adult Rhabdomyosarcoma | 2,853 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2584834 |
| 139 | = | Childhood Rhabdomyosarcoma | 2,853 | 95.2 | Medium confidence | pubmed | inputs
ranking row 2584835 |
| 141 | = | Oropharyngeal Carcinoma | 2,774 | 95.1 | Medium confidence | pubmed | inputs
ranking row 2584836 |
| 142 | = | Carcinoma In Situ | 2,702 | 95.1 | Medium confidence | pubmed | inputs
ranking row 2584837 |
| 143 | = | Gallbladder Carcinoma | 2,700 | 95.1 | Medium confidence | pubmed | inputs
ranking row 2584838 |
| 144 | = | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 2,662 | 95 | Medium confidence | pubmed | inputs
ranking row 2584839 |
| 145 | = | Endometrial Clear Cell Adenocarcinoma | 2,630 | 95 | Medium confidence | pubmed | inputs
ranking row 2584840 |
| 146 | = | Anaplastic Lymphoma | 2,597 | 95 | Medium confidence | pubmed | inputs
ranking row 2584841 |
| 147 | = | Early Stage Breast Carcinoma | 2,583 | 94.9 | Medium confidence | pubmed | inputs
ranking row 2584842 |
| 148 | = | Colon Adenocarcinoma | 2,562 | 94.9 | Medium confidence | pubmed | inputs
ranking row 2584843 |
| 149 | = | Malignant Oropharyngeal Neoplasm | 2,550 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2584844 |
| 150 | = | HER2-Positive Breast Carcinoma | 2,511 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2584845 |
| 151 | = | Adult Medulloblastoma | 2,497 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2584846 |
| 151 | = | Childhood Medulloblastoma | 2,497 | 94.8 | Medium confidence | pubmed | inputs
ranking row 2584847 |
| 153 | = | Basal Cell Carcinoma | 2,473 | 94.7 | Medium confidence | pubmed | inputs
ranking row 2584848 |
| 154 | = | Laryngeal Carcinoma | 2,450 | 94.7 | Medium confidence | pubmed | inputs
ranking row 2584849 |
| 155 | = | Invasive Breast Carcinoma of No Special Type | 2,413 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2584850 |
| 156 | = | Carcinomatosis | 2,341 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2584851 |
| 157 | = | Adult Leiomyosarcoma | 2,329 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2584852 |
| 157 | = | Childhood Leiomyosarcoma | 2,329 | 94.6 | Medium confidence | pubmed | inputs
ranking row 2584853 |
| 159 | = | Adult Liposarcoma | 2,299 | 94.5 | Medium confidence | pubmed | inputs
ranking row 2584854 |
| 159 | = | Childhood Liposarcoma | 2,299 | 94.5 | Medium confidence | pubmed | inputs
ranking row 2584855 |
| 161 | = | Malignant Gallbladder Neoplasm | 2,222 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2584856 |
| 162 | = | Malignant Bone Neoplasm | 2,193 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2584857 |
| 163 | = | Hodgkin Lymphoma | 2,178 | 94.4 | Medium confidence | pubmed | inputs
ranking row 2584858 |
| 164 | = | Papillary Carcinoma | 2,149 | 94.3 | Medium confidence | pubmed | inputs
ranking row 2584859 |
| 165 | = | Malignant Mesothelioma | 2,145 | 94.3 | Medium confidence | pubmed | inputs
ranking row 2584860 |
| 166 | = | Kidney Wilms Tumor | 2,071 | 94.3 | Medium confidence | pubmed | inputs
ranking row 2584861 |
| 167 | = | Hereditary Malignant Neoplasm | 2,063 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2584862 |
| 168 | = | Malignant Laryngeal Neoplasm | 2,031 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2584863 |
| 169 | = | Colorectal Adenocarcinoma | 1,998 | 94.2 | Medium confidence | pubmed | inputs
ranking row 2584864 |
| 170 | = | Thyroid Gland Medullary Carcinoma | 1,986 | 94.1 | Medium confidence | pubmed | inputs
ranking row 2584865 |
| 171 | = | Esophageal Adenocarcinoma | 1,977 | 94.1 | Medium confidence | pubmed | inputs
ranking row 2584866 |
| 172 | = | Adult Angiosarcoma | 1,968 | 94 | Medium confidence | pubmed | inputs
ranking row 2584868 |
| 172 | = | Prostate Adenocarcinoma | 1,968 | 94 | Medium confidence | pubmed | inputs
ranking row 2584867 |
| 174 | = | Childhood Angiosarcoma | 1,967 | 94 | Medium confidence | pubmed | inputs
ranking row 2584869 |
| 175 | = | Central Nervous System Lymphoma | 1,873 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2584870 |
| 176 | = | Invasive Carcinoma | 1,872 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2584871 |
| 177 | = | Oropharyngeal Squamous Cell Carcinoma | 1,869 | 93.9 | Medium confidence | pubmed | inputs
ranking row 2584872 |
| 178 | = | Primary Brain Tumor | 1,865 | 93.8 | Medium confidence | pubmed | inputs
ranking row 2584873 |
| 179 | = | Childhood Kidney Wilms Tumor | 1,858 | 93.8 | Medium confidence | pubmed | inputs
ranking row 2584874 |
| 180 | = | Malignant Female Reproductive System Neoplasm | 1,820 | 93.8 | Medium confidence | pubmed | inputs
ranking row 2584875 |
| 181 | = | Malignant Testicular Germ Cell Tumor | 1,819 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2584876 |
| 182 | = | Luminal A Breast Carcinoma | 1,807 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2584877 |
| 183 | = | Malignant Testicular Neoplasm | 1,806 | 93.7 | Medium confidence | pubmed | inputs
ranking row 2584878 |
| 184 | = | Invasive Malignant Neoplasm | 1,770 | 93.6 | Medium confidence | pubmed | inputs
ranking row 2584879 |
| 184 | = | Malignant Biliary Tract Neoplasm | 1,770 | 93.6 | Medium confidence | pubmed | inputs
ranking row 2584880 |
| 186 | = | Primary Central Nervous System Lymphoma | 1,746 | 93.6 | Medium confidence | pubmed | inputs
ranking row 2584881 |
| 187 | = | Early Gastric Carcinoma | 1,726 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2584882 |
| 188 | = | Renal Pelvis and Ureter Urothelial Carcinoma | 1,722 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2584883 |
| 189 | = | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | 1,654 | 93.5 | Medium confidence | pubmed | inputs
ranking row 2584884 |
| 190 | = | High-Grade Serous Ovarian Cancer | 1,648 | 93.4 | Medium confidence | pubmed | inputs
ranking row 2584885 |
| 191 | = | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1,579 | 93.4 | Medium confidence | pubmed | inputs
ranking row 2584886 |
| 192 | = | Peritoneal Carcinomatosis | 1,539 | 93.3 | Medium confidence | pubmed | inputs
ranking row 2584887 |
| 193 | = | Renal Pelvis and Ureter Carcinoma | 1,519 | 93.3 | Medium confidence | pubmed | inputs
ranking row 2584888 |
| 194 | = | Rectal Adenocarcinoma | 1,507 | 93.3 | Medium confidence | pubmed | inputs
ranking row 2584889 |
| 195 | = | Thyroid Gland Spindle Epithelial Tumor with Thymus-Like Elements | 1,506 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2584890 |
| 196 | = | Luminal B Breast Carcinoma | 1,505 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2584891 |
| 197 | = | Breast Carcinoma In Situ | 1,457 | 93.2 | Medium confidence | pubmed | inputs
ranking row 2584892 |
| 198 | = | Classic Hodgkin Lymphoma | 1,452 | 93.1 | Medium confidence | pubmed | inputs
ranking row 2584893 |
| 199 | = | Mucinous Adenocarcinoma | 1,446 | 93.1 | Medium confidence | pubmed | inputs
ranking row 2584894 |
| 200 | = | Head and Neck Carcinoma | 1,439 | 93.1 | Medium confidence | pubmed | inputs
ranking row 2584895 |
| 201 | = | Anal Carcinoma | 1,421 | 93 | Medium confidence | pubmed | inputs
ranking row 2584896 |
| 202 | = | Intraductal Carcinoma | 1,399 | 93 | Medium confidence | pubmed | inputs
ranking row 2584897 |
| 203 | = | Follicular Lymphoma | 1,390 | 93 | Medium confidence | pubmed | inputs
ranking row 2584898 |
| 204 | = | Paget Disease | 1,360 | 92.9 | Medium confidence | pubmed | inputs
ranking row 2584899 |
| 205 | = | Adult Anaplastic Large Cell Lymphoma | 1,354 | 92.9 | Medium confidence | pubmed | inputs
ranking row 2584900 |
| 205 | = | Childhood Anaplastic Large Cell Lymphoma | 1,354 | 92.9 | Medium confidence | pubmed | inputs
ranking row 2584901 |
| 207 | = | Cystadenocarcinoma | 1,323 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2584902 |
| 208 | = | Marginal Zone Lymphoma | 1,321 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2584903 |
| 209 | = | Differentiated Thyroid Gland Carcinoma | 1,301 | 92.8 | Medium confidence | pubmed | inputs
ranking row 2584904 |
| 210 | = | Adult Fibrosarcoma | 1,299 | 92.7 | Medium confidence | pubmed | inputs
ranking row 2584905 |
| 210 | = | Childhood Fibrosarcoma | 1,299 | 92.7 | Medium confidence | pubmed | inputs
ranking row 2584906 |
| 212 | = | B Acute Lymphoblastic Leukemia | 1,294 | 92.7 | Medium confidence | pubmed | inputs
ranking row 2584907 |
| 213 | = | Malignant Anal Neoplasm | 1,291 | 92.6 | Medium confidence | pubmed | inputs
ranking row 2584908 |
| 214 | = | Oral Cavity Carcinoma | 1,266 | 92.6 | Medium confidence | pubmed | inputs
ranking row 2584909 |
| 215 | = | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | 1,259 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2584910 |
| 216 | = | Ewing Sarcoma | 1,246 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2584911 |
| 216 | = | Serous Cystadenocarcinoma | 1,246 | 92.5 | Medium confidence | pubmed | inputs
ranking row 2584912 |
| 218 | = | Uveal Melanoma | 1,244 | 92.4 | Medium confidence | pubmed | inputs
ranking row 2584913 |
| 219 | = | Pleural Malignant Mesothelioma | 1,240 | 92.4 | Medium confidence | pubmed | inputs
ranking row 2584914 |
| 220 | = | Myosarcoma | 1,229 | 92.4 | Medium confidence | pubmed | inputs
ranking row 2584915 |
| 221 | = | Rhabdomyosarcoma | 1,225 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2584916 |
| 222 | = | Atypical Teratoid/Rhabdoid Tumor | 1,204 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2584917 |
| 223 | = | Retinoblastoma | 1,201 | 92.3 | Medium confidence | pubmed | inputs
ranking row 2584918 |
| 224 | = | Malignant Uterine Neoplasm | 1,193 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2584919 |
| 225 | = | Cervical Squamous Cell Carcinoma | 1,178 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2584920 |
| 226 | = | Medulloblastoma | 1,172 | 92.2 | Medium confidence | pubmed | inputs
ranking row 2584921 |
| 227 | = | Adult Synovial Sarcoma | 1,162 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2584922 |
| 227 | = | Childhood Synovial Sarcoma | 1,162 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2584923 |
| 229 | = | Childhood Burkitt Lymphoma | 1,126 | 92.1 | Medium confidence | pubmed | inputs
ranking row 2584924 |
| 230 | = | Adult Burkitt Lymphoma | 1,124 | 92 | Medium confidence | pubmed | inputs
ranking row 2584925 |
| 231 | = | Primary Myelofibrosis | 1,119 | 92 | Medium confidence | pubmed | inputs
ranking row 2584926 |
| 232 | = | Penile Carcinoma | 1,112 | 92 | Medium confidence | pubmed | inputs
ranking row 2584927 |
| 233 | = | T Acute Lymphoblastic Leukemia | 1,090 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2584928 |
| 234 | = | Fibrosarcoma | 1,074 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2584929 |
| 234 | = | Tongue Carcinoma | 1,074 | 91.9 | Medium confidence | pubmed | inputs
ranking row 2584930 |
| 236 | = | Tongue Squamous Cell Carcinoma | 1,066 | 91.8 | Medium confidence | pubmed | inputs
ranking row 2584931 |
| 237 | = | Papillary Renal Cell Carcinoma | 1,064 | 91.8 | Medium confidence | pubmed | inputs
ranking row 2584932 |
| 238 | = | Laryngeal Squamous Cell Carcinoma | 1,031 | 91.7 | Medium confidence | pubmed | inputs
ranking row 2584933 |
| 239 | = | Malignant Penile Neoplasm | 1,025 | 91.7 | Medium confidence | pubmed | inputs
ranking row 2584934 |
| 240 | = | Medulloblastoma, Not Otherwise Specified | 1,015 | 91.7 | Medium confidence | pubmed | inputs
ranking row 2584935 |
| 241 | = | Adult Penile Carcinoma | 1,013 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2584936 |
| 242 | = | Malignant Peritoneal Neoplasm | 1,004 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2584937 |
| 243 | = | Endometrioid Adenocarcinoma | 1,001 | 91.6 | Medium confidence | pubmed | inputs
ranking row 2584938 |
| 244 | = | Mantle Cell Lymphoma | 992 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2584939 |
| 245 | = | Vulvar Carcinoma | 967 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2584940 |
| 246 | = | Malignant Nasopharyngeal Neoplasm | 952 | 91.5 | Medium confidence | pubmed | inputs
ranking row 2584941 |
| 247 | = | Lung Non-Squamous Non-Small Cell Carcinoma | 943 | 91.4 | Medium confidence | pubmed | inputs
ranking row 2584942 |
| 248 | = | Angiosarcoma | 940 | 91.4 | Medium confidence | pubmed | inputs
ranking row 2584944 |
| 248 | = | Breast Adenocarcinoma | 940 | 91.4 | Medium confidence | pubmed | inputs
ranking row 2584943 |
| 250 | = | Liposarcoma | 929 | 91.3 | Medium confidence | pubmed | inputs
ranking row 2584945 |
| 251 | = | Malignant Intestinal Neoplasm | 922 | 91.3 | Medium confidence | pubmed | inputs
ranking row 2584946 |
| 251 | = | Mycosis Fungoides | 922 | 91.3 | Medium confidence | pubmed | inputs
ranking row 2584947 |
| 253 | = | Signet Ring Cell Adenocarcinoma | 921 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2584948 |
| 254 | = | Malignant Oral Cavity Neoplasm | 910 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2584949 |
| 255 | = | Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | 899 | 91.2 | Medium confidence | pubmed | inputs
ranking row 2584950 |
| 256 | = | Adenoid Cystic Carcinoma | 890 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2584951 |
| 257 | = | Testicular Choriocarcinoma | 886 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2584952 |
| 257 | = | Uterine Corpus Choriocarcinoma | 886 | 91.1 | Medium confidence | pubmed | inputs
ranking row 2584953 |
| 259 | = | Invasive Breast Lobular Carcinoma | 881 | 91 | Medium confidence | pubmed | inputs
ranking row 2584954 |
| 260 | = | Leiomyosarcoma | 878 | 91 | Medium confidence | pubmed | inputs
ranking row 2584955 |
| 261 | = | Kaposi Sarcoma | 871 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2584956 |
| 262 | = | Malignant Vulvar Neoplasm | 870 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2584957 |
| 263 | = | Non-Muscle Invasive Bladder Carcinoma | 866 | 90.9 | Medium confidence | pubmed | inputs
ranking row 2584958 |
| 264 | = | High Risk Neuroblastoma | 855 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2584959 |
| 265 | = | Pancreatic Signet Ring Cell Adenocarcinoma | 853 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2584960 |
| 266 | = | Bladder Urothelial Carcinoma | 839 | 90.8 | Medium confidence | pubmed | inputs
ranking row 2584961 |
| 267 | = | Merkel Cell Carcinoma | 834 | 90.7 | Medium confidence | pubmed | inputs
ranking row 2584962 |
| 268 | = | Malignant Tongue Neoplasm | 833 | 90.7 | Medium confidence | pubmed | inputs
ranking row 2584963 |
| 269 | = | Wilms Tumor | 828 | 90.7 | Medium confidence | pubmed | inputs
ranking row 2584964 |
| 270 | = | Chondrosarcoma | 798 | 90.6 | Medium confidence | pubmed | inputs
ranking row 2584965 |
| 271 | = | Adult Hepatocellular Carcinoma | 794 | 90.6 | Medium confidence | pubmed | inputs
ranking row 2584966 |
| 272 | = | Childhood Renal Cell Carcinoma | 792 | 90.6 | Medium confidence | pubmed | inputs
ranking row 2584967 |
| 273 | = | Carcinoma of Unknown Primary | 791 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2584968 |
| 274 | = | Acute Promyelocytic Leukemia | 788 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2584969 |
| 275 | = | Childhood Hepatocellular Carcinoma | 785 | 90.5 | Medium confidence | pubmed | inputs
ranking row 2584970 |
| 276 | = | Hypopharyngeal Carcinoma | 772 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2584971 |
| 277 | = | Large Duct Intrahepatic Cholangiocarcinoma | 771 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2584972 |
| 278 | = | Large Cell Neuroendocrine Carcinoma | 770 | 90.4 | Medium confidence | pubmed | inputs
ranking row 2584973 |
| 279 | = | Adult Classic Hodgkin Lymphoma | 763 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2584974 |
| 280 | = | Thyroid Gland Papillary Microcarcinoma | 762 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2584975 |
| 281 | = | Burkitt Lymphoma | 758 | 90.3 | Medium confidence | pubmed | inputs
ranking row 2584976 |
| 282 | = | Thyroid Gland Follicular Carcinoma | 753 | 90.2 | Medium confidence | pubmed | inputs
ranking row 2584977 |
| 283 | = | Aggressive Non-Hodgkin Lymphoma | 751 | 90.2 | Medium confidence | pubmed | inputs
ranking row 2584978 |
| 284 | = | Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion | 750 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2584979 |
| 285 | = | Sarcomatoid Carcinoma | 742 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2584980 |
| 286 | = | Diffuse Midline Glioma | 732 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2584982 |
| 286 | = | Thymus Carcinoma | 732 | 90.1 | Medium confidence | pubmed | inputs
ranking row 2584981 |
| 288 | = | Polycythemia Vera | 730 | 90 | Medium confidence | pubmed | inputs
ranking row 2584983 |
| 289 | = | Mucosal Melanoma | 720 | 90 | Medium confidence | pubmed | inputs
ranking row 2584984 |
| 290 | = | Peripheral T-Cell Lymphoma, Not Otherwise Specified | 715 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2584985 |
| 291 | = | Bone Sarcoma | 713 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2584986 |
| 292 | = | Adrenal Cortical Carcinoma | 710 | 89.9 | Medium confidence | pubmed | inputs
ranking row 2584987 |
| 293 | = | Adult Undifferentiated Pleomorphic Sarcoma | 702 | 89.8 | Medium confidence | pubmed | inputs
ranking row 2584988 |
| 293 | = | Childhood Undifferentiated Pleomorphic Sarcoma | 702 | 89.8 | Medium confidence | pubmed | inputs
ranking row 2584989 |
| 295 | = | Undifferentiated Carcinoma | 693 | 89.8 | Medium confidence | pubmed | inputs
ranking row 2584990 |
| 296 | = | Adult Lymphoblastic Lymphoma | 688 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2584992 |
| 296 | = | Childhood Lymphoblastic Lymphoma | 688 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2584993 |
| 296 | = | Lymphoblastic Lymphoma | 688 | 89.7 | Medium confidence | pubmed | inputs
ranking row 2584991 |
| 299 | = | Gastroesophageal Junction Adenocarcinoma | 687 | 89.6 | Medium confidence | pubmed | inputs
ranking row 2584994 |
| 300 | = | Poorly Differentiated Thyroid Gland Carcinoma | 684 | 89.6 | Medium confidence | pubmed | inputs
ranking row 2584995 |
| 301 | = | ALK-Positive Lung Non-Small Cell Carcinoma | 682 | 89.6 | Medium confidence | pubmed | inputs
ranking row 2584996 |
| 302 | = | Small Lymphocytic Lymphoma | 653 | 89.5 | Medium confidence | pubmed | inputs
ranking row 2584997 |
| 303 | = | Dedifferentiated Liposarcoma | 652 | 89.5 | Medium confidence | pubmed | inputs
ranking row 2584998 |
| 304 | = | Pulmonary Artery Intimal Sarcoma | 650 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2584999 |
| 305 | = | Adult Malignant Peripheral Nerve Sheath Tumor | 649 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2585001 |
| 305 | = | Anaplastic Large Cell Lymphoma | 649 | 89.4 | Medium confidence | pubmed | inputs
ranking row 2585000 |
| 307 | = | Thyroid Gland Anaplastic Carcinoma | 647 | 89.3 | Medium confidence | pubmed | inputs
ranking row 2585002 |
| 308 | = | Acral Lentiginous Melanoma | 645 | 89.3 | Medium confidence | pubmed | inputs
ranking row 2585003 |
| 309 | = | Breast Lobular Carcinoma | 641 | 89.3 | Medium confidence | pubmed | inputs
ranking row 2585004 |
| 310 | = | Cervical Adenosquamous Carcinoma | 635 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2585005 |
| 311 | = | Extrahepatic Cholangiocarcinoma | 634 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2585007 |
| 311 | = | Pancreatic Adenosquamous Carcinoma | 634 | 89.2 | Medium confidence | pubmed | inputs
ranking row 2585006 |
| 313 | = | Male Breast Carcinoma | 631 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2585008 |
| 314 | = | Ovarian Mucinous Adenocarcinoma | 630 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2585009 |
| 315 | = | Chordoma | 602 | 89.1 | Medium confidence | pubmed | inputs
ranking row 2585010 |
| 316 | = | Myelodysplastic/Myeloproliferative Neoplasm | 597 | 89 | Medium confidence | pubmed | inputs
ranking row 2585011 |
| 317 | = | Germinoma | 593 | 89 | Medium confidence | pubmed | inputs
ranking row 2585012 |
| 318 | = | Malignant Hypopharyngeal Neoplasm | 581 | 89 | Medium confidence | pubmed | inputs
ranking row 2585013 |
| 319 | = | Lung Non-Small Cell Carcinoma with EGFR Mutation | 580 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2585014 |
| 320 | = | Hilar Cholangiocarcinoma | 578 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2585015 |
| 321 | = | Cervical Adenocarcinoma | 571 | 88.9 | Medium confidence | pubmed | inputs
ranking row 2585016 |
| 322 | = | Pancreatic Undifferentiated Carcinoma | 564 | 88.8 | Medium confidence | pubmed | inputs
ranking row 2585017 |
| 322 | = | Waldenstrom Macroglobulinemia | 564 | 88.8 | Medium confidence | pubmed | inputs
ranking row 2585018 |
| 324 | = | Choroid Melanoma | 550 | 88.8 | Medium confidence | pubmed | inputs
ranking row 2585019 |
| 325 | = | Essential Thrombocythemia | 548 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2585020 |
| 326 | = | Chromophobe Renal Cell Carcinoma | 546 | 88.7 | Medium confidence | pubmed | inputs
ranking row 2585021 |
| 327 | = | Cutaneous Lymphoma | 543 | 88.6 | Medium confidence | pubmed | inputs
ranking row 2585022 |
| 328 | = | Nasal Type Extranodal NK/T-Cell Lymphoma | 526 | 88.6 | Medium confidence | pubmed | inputs
ranking row 2585024 |
| 328 | = | Poorly Differentiated Adenocarcinoma | 526 | 88.6 | Medium confidence | pubmed | inputs
ranking row 2585023 |
| 330 | = | Malignant Neoplasm of Unknown Primary | 520 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2585025 |
| 331 | = | Primary Cutaneous Lymphoma | 519 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2585026 |
| 332 | = | Malignant Bile Duct Neoplasm | 509 | 88.5 | Medium confidence | pubmed | inputs
ranking row 2585027 |
| 333 | = | Pelvic Soft Tissue Sarcoma | 506 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2585028 |
| 334 | = | Adult T-Cell Leukemia/Lymphoma | 504 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2585029 |
| 335 | = | Hepatoblastoma | 499 | 88.4 | Medium confidence | pubmed | inputs
ranking row 2585030 |
| 336 | = | Distal Cholangiocarcinoma | 497 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2585031 |
| 337 | = | Clear Cell Adenocarcinoma | 495 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2585032 |
| 338 | = | Melanoma In Situ | 491 | 88.3 | Medium confidence | pubmed | inputs
ranking row 2585033 |
| 339 | = | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | 488 | 88.2 | Medium confidence | pubmed | inputs
ranking row 2585034 |
| 340 | = | Malignant Salivary Gland Neoplasm | 474 | 88.2 | Medium confidence | pubmed | inputs
ranking row 2585035 |
| 341 | = | Breast Implant-Associated Anaplastic Large Cell Lymphoma | 473 | 88.2 | Medium confidence | pubmed | inputs
ranking row 2585036 |
| 342 | = | Retroperitoneal Sarcoma | 472 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2585037 |
| 343 | = | Childhood Leukemia | 471 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2585038 |
| 344 | = | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 469 | 88.1 | Medium confidence | pubmed | inputs
ranking row 2585039 |
| 345 | = | Adult Epithelioid Hemangioendothelioma | 468 | 88 | Medium confidence | pubmed | inputs
ranking row 2585041 |
| 345 | = | Childhood Epithelioid Hemangioendothelioma | 468 | 88 | Medium confidence | pubmed | inputs
ranking row 2585040 |
| 347 | = | Parathyroid Gland Carcinoma | 467 | 88 | Medium confidence | pubmed | inputs
ranking row 2585042 |
| 348 | = | Uterine Corpus Sarcoma | 465 | 87.9 | Medium confidence | pubmed | inputs
ranking row 2585043 |
| 349 | = | High Grade B-Cell Lymphoma | 464 | 87.9 | Medium confidence | pubmed | inputs
ranking row 2585044 |
| 350 | = | Parathyroid Carcinoma | 463 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585046 |
| 350 | = | Vaginal Yolk Sac Tumor | 463 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585045 |
| 352 | = | Adult Yolk Sac Tumor | 462 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585047 |
| 352 | = | Ovarian Yolk Sac Tumor | 462 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585048 |
| 352 | = | Testicular Yolk Sac Tumor | 462 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585049 |
| 352 | = | Xanthogranuloma | 462 | 87.8 | Medium confidence | pubmed | inputs
ranking row 2585050 |
| 356 | = | Intrathyroid Thymic Carcinoma | 453 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2585051 |
| 357 | = | Endocervical Adenocarcinoma | 450 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2585052 |
| 358 | = | Acral Melanoma | 448 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2585054 |
| 358 | = | Stromal Sarcoma | 448 | 87.6 | Medium confidence | pubmed | inputs
ranking row 2585053 |
| 360 | = | Invasive Cervical Carcinoma | 446 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2585055 |
| 361 | = | Solid Pseudopapillary Neoplasm | 445 | 87.5 | Medium confidence | pubmed | inputs
ranking row 2585056 |
| 362 | = | Endometrial Adenocarcinoma | 442 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2585057 |
| 363 | = | Carcinosarcoma | 437 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2585058 |
| 364 | = | Glioblastoma, IDH-Wildtype | 436 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2585059 |
| 364 | = | Small Cell Neuroendocrine Carcinoma | 436 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2585060 |
| 364 | = | Synovial Sarcoma | 436 | 87.4 | Medium confidence | pubmed | inputs
ranking row 2585061 |
| 367 | = | Well-Differentiated Liposarcoma | 434 | 87.3 | Medium confidence | pubmed | inputs
ranking row 2585062 |
| 368 | = | Secondary Acute Myeloid Leukemia | 433 | 87.2 | Medium confidence | pubmed | inputs
ranking row 2585063 |
| 369 | = | Early Stage Hepatocellular Carcinoma | 422 | 87.2 | Medium confidence | pubmed | inputs
ranking row 2585064 |
| 370 | = | Neck Carcinoma | 420 | 87.2 | Medium confidence | pubmed | inputs
ranking row 2585065 |
| 371 | = | Lymphoplasmacytic Lymphoma | 412 | 87.1 | Medium confidence | pubmed | inputs
ranking row 2585066 |
| 372 | = | Anal Squamous Cell Carcinoma | 411 | 87.1 | Medium confidence | pubmed | inputs
ranking row 2585067 |
| 373 | = | Vaginal Carcinoma | 406 | 87 | Medium confidence | pubmed | inputs
ranking row 2585068 |
| 374 | = | Breast Metaplastic Carcinoma | 405 | 87 | Medium confidence | pubmed | inputs
ranking row 2585069 |
| 375 | = | Hereditary Breast Carcinoma | 404 | 87 | Medium confidence | pubmed | inputs
ranking row 2585070 |
| 376 | = | Seminoma | 403 | 86.9 | Medium confidence | pubmed | inputs
ranking row 2585071 |
| 377 | = | Platinum-Resistant Ovarian Carcinoma | 398 | 86.9 | Medium confidence | pubmed | inputs
ranking row 2585072 |
| 378 | = | Ampulla of Vater Carcinoma | 395 | 86.9 | Medium confidence | pubmed | inputs
ranking row 2585073 |
| 379 | = | Plasmacytoid Dendritic Cell Neoplasm | 392 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2585074 |
| 380 | = | Mucoepidermoid Carcinoma | 391 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2585075 |
| 381 | = | Uterine Corpus Leiomyosarcoma | 390 | 86.8 | Medium confidence | pubmed | inputs
ranking row 2585076 |
| 382 | = | Hypopharyngeal Squamous Cell Carcinoma | 389 | 86.7 | Medium confidence | pubmed | inputs
ranking row 2585077 |
| 383 | = | HER2-Low Breast Carcinoma | 387 | 86.7 | Medium confidence | pubmed | inputs
ranking row 2585078 |
| 383 | = | Indolent Non-Hodgkin Lymphoma | 387 | 86.7 | Medium confidence | pubmed | inputs
ranking row 2585079 |
| 385 | = | Myxofibrosarcoma | 385 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2585080 |
| 386 | = | Anaplastic Astrocytoma | 383 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2585081 |
| 387 | = | Invasive Cutaneous Melanoma | 382 | 86.6 | Medium confidence | pubmed | inputs
ranking row 2585082 |
| 388 | = | Invasive Urothelial Carcinoma | 381 | 86.5 | Medium confidence | pubmed | inputs
ranking row 2585083 |
| 388 | = | Pineal Region Germinoma | 381 | 86.5 | Medium confidence | pubmed | inputs
ranking row 2585084 |
| 390 | = | Penile Squamous Cell Carcinoma | 379 | 86.5 | Medium confidence | pubmed | inputs
ranking row 2585085 |
| 391 | = | Extraosseous Plasmacytoma | 378 | 86.4 | Medium confidence | pubmed | inputs
ranking row 2585086 |
| 391 | = | Lymphoepithelial Carcinoma | 378 | 86.4 | Medium confidence | pubmed | inputs
ranking row 2585087 |
| 393 | = | Malignant Vaginal Neoplasm | 373 | 86.4 | Medium confidence | pubmed | inputs
ranking row 2585088 |
| 394 | = | Adult B Acute Lymphoblastic Leukemia | 372 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2585090 |
| 394 | = | Myelodysplastic Syndrome/Acute Myeloid Leukemia | 372 | 86.3 | Medium confidence | pubmed | inputs
ranking row 2585089 |
| 396 | = | Primary Mediastinal Large B-Cell Lymphoma | 371 | 86.2 | Medium confidence | pubmed | inputs
ranking row 2585091 |
| 397 | = | Salivary Gland Carcinoma | 359 | 86.2 | Medium confidence | pubmed | inputs
ranking row 2585092 |
| 398 | = | Chronic Myelomonocytic Leukemia | 358 | 86.2 | Medium confidence | pubmed | inputs
ranking row 2585093 |
| 399 | = | Childhood B Acute Lymphoblastic Leukemia | 353 | 86.1 | Medium confidence | pubmed | inputs
ranking row 2585094 |
| 400 | = | Mixed Phenotype Acute Leukemia | 352 | 86.1 | Medium confidence | pubmed | inputs
ranking row 2585096 |
| 400 | = | Skin Squamous Cell Carcinoma | 352 | 86.1 | Medium confidence | pubmed | inputs
ranking row 2585095 |
| 402 | = | Low Grade Appendix Mucinous Neoplasm | 351 | 86 | Medium confidence | pubmed | inputs
ranking row 2585098 |
| 402 | = | Plasmacytoma | 351 | 86 | Medium confidence | pubmed | inputs
ranking row 2585097 |
| 404 | = | Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma | 350 | 86 | Medium confidence | pubmed | inputs
ranking row 2585099 |
| 405 | = | Childhood Embryonal Rhabdomyosarcoma | 346 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2585100 |
| 406 | = | Urothelial Carcinoma, High Grade | 343 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2585101 |
| 407 | = | Combined Hepatocellular Carcinoma and Cholangiocarcinoma | 342 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2585102 |
| 407 | = | Sezary Syndrome | 342 | 85.9 | Medium confidence | pubmed | inputs
ranking row 2585103 |
| 409 | = | Molar Pregnancy | 341 | 85.8 | Medium confidence | pubmed | inputs
ranking row 2585104 |
| 410 | = | Intravascular Large B-Cell Lymphoma | 339 | 85.8 | Medium confidence | pubmed | inputs
ranking row 2585105 |
| 411 | = | Acute Monocytic Leukemia | 338 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2585106 |
| 412 | = | Malignant Genitourinary System Neoplasm | 334 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2585107 |
| 413 | = | Extramammary Paget Disease | 333 | 85.7 | Medium confidence | pubmed | inputs
ranking row 2585108 |
| 414 | = | Serous Tubal Intraepithelial Carcinoma | 332 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2585109 |
| 415 | = | Pancreatic Medullary Carcinoma | 324 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2585110 |
| 416 | = | Appendix Mucinous Neoplasm | 322 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2585112 |
| 416 | = | NUT Carcinoma | 322 | 85.6 | Medium confidence | pubmed | inputs
ranking row 2585111 |
| 418 | = | Choriocarcinoma | 321 | 85.5 | Medium confidence | pubmed | inputs
ranking row 2585113 |
| 419 | = | Malignant Myoepithelioma | 319 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2585114 |
| 420 | = | Childhood Atypical Teratoid/Rhabdoid Tumor | 317 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2585115 |
| 421 | = | Salivary Duct Carcinoma | 312 | 85.4 | Medium confidence | pubmed | inputs
ranking row 2585116 |
| 422 | = | Vulvar Squamous Cell Carcinoma | 311 | 85.3 | Medium confidence | pubmed | inputs
ranking row 2585117 |
| 423 | = | Breast Secretory Carcinoma | 309 | 85.3 | Medium confidence | pubmed | inputs
ranking row 2585118 |
| 424 | = | Meningeal Carcinomatosis | 306 | 85.3 | Medium confidence | pubmed | inputs
ranking row 2585119 |
| 425 | = | Moderately Differentiated Adenocarcinoma | 304 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2585120 |
| 426 | = | Malignant Endocrine Neoplasm | 302 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2585121 |
| 427 | = | Salivary Gland Myoepithelial Carcinoma | 301 | 85.2 | Medium confidence | pubmed | inputs
ranking row 2585122 |
| 428 | = | Malignant Central Nervous System Neoplasm | 298 | 85.1 | Medium confidence | pubmed | inputs
ranking row 2585123 |
| 428 | = | Small Hepatocellular Carcinoma | 298 | 85.1 | Medium confidence | pubmed | inputs
ranking row 2585124 |
| 430 | = | Pharyngeal Carcinoma | 296 | 85.1 | Medium confidence | pubmed | inputs
ranking row 2585126 |
| 430 | = | Undifferentiated Sarcoma | 296 | 85.1 | Medium confidence | pubmed | inputs
ranking row 2585125 |
| 432 | = | Malignant Pelvic Neoplasm | 295 | 85 | Medium confidence | pubmed | inputs
ranking row 2585127 |
| 432 | = | Parotid Gland Carcinoma | 295 | 85 | Medium confidence | pubmed | inputs
ranking row 2585128 |
| 434 | = | Spindle Cell Sarcoma | 293 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2585129 |
| 435 | = | Central Nervous System Embryonal Carcinoma | 292 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2585130 |
| 435 | = | Ovarian Embryonal Carcinoma | 292 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2585131 |
| 435 | = | Testicular Embryonal Carcinoma | 292 | 84.9 | Medium confidence | pubmed | inputs
ranking row 2585132 |
| 438 | = | Epithelioid Sarcoma | 289 | 84.8 | Medium confidence | pubmed | inputs
ranking row 2585133 |
| 439 | = | Adult Epithelioid Sarcoma | 287 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2585134 |
| 439 | = | Childhood Epithelioid Sarcoma | 287 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2585135 |
| 441 | = | Retroperitoneal Liposarcoma | 285 | 84.7 | Medium confidence | pubmed | inputs
ranking row 2585136 |
| 442 | = | Acute Undifferentiated Leukemia | 284 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2585137 |
| 443 | = | Acinar Cell Carcinoma | 282 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2585138 |
| 444 | = | Keratoacanthoma | 278 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2585139 |
| 444 | = | Skin Keratoacanthoma | 278 | 84.6 | Medium confidence | pubmed | inputs
ranking row 2585140 |
| 446 | = | Malignant Neoplasm of Lung - Multiple Primary Sites | 277 | 84.5 | Medium confidence | pubmed | inputs
ranking row 2585141 |
| 447 | = | Malignant Abdominal Neoplasm | 274 | 84.5 | Medium confidence | pubmed | inputs
ranking row 2585142 |
| 448 | = | Peritoneal Malignant Mesothelioma | 273 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2585143 |
| 449 | = | Small Intestinal Adenocarcinoma | 266 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2585144 |
| 450 | = | Pseudomyxoma Peritonei | 264 | 84.4 | Medium confidence | pubmed | inputs
ranking row 2585145 |
| 451 | = | Childhood Alveolar Rhabdomyosarcoma | 263 | 84.3 | Medium confidence | pubmed | inputs
ranking row 2585146 |
| 452 | = | Basal-Like Breast Carcinoma | 262 | 84.3 | Medium confidence | pubmed | inputs
ranking row 2585149 |
| 452 | = | Extranodal Lymphoma | 262 | 84.3 | Medium confidence | pubmed | inputs
ranking row 2585147 |
| 452 | = | Uterine Carcinosarcoma | 262 | 84.3 | Medium confidence | pubmed | inputs
ranking row 2585148 |
| 455 | = | Conjunctival Melanoma | 261 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2585150 |
| 455 | = | Liver Carcinoma | 261 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2585151 |
| 455 | = | Malignant Pharyngeal Neoplasm | 261 | 84.2 | Medium confidence | pubmed | inputs
ranking row 2585152 |
| 458 | = | Hereditary Leiomyomatosis and Renal Cell Carcinoma | 259 | 84.1 | Medium confidence | pubmed | inputs
ranking row 2585153 |
| 459 | = | Malignant Appendix Neoplasm | 258 | 84.1 | Medium confidence | pubmed | inputs
ranking row 2585154 |
| 460 | = | Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 254 | 84 | Medium confidence | pubmed | inputs
ranking row 2585155 |
| 461 | = | Lung Large Cell Carcinoma | 253 | 84 | Medium confidence | pubmed | inputs
ranking row 2585156 |
| 462 | = | Adult Alveolar Soft Part Sarcoma | 250 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2585157 |
| 462 | = | Childhood Alveolar Soft Part Sarcoma | 250 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2585158 |
| 462 | = | Grade 3a Follicular Lymphoma | 250 | 83.9 | Medium confidence | pubmed | inputs
ranking row 2585159 |
| 465 | = | Malignant Thoracic Neoplasm | 248 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585160 |
| 466 | = | Adenosquamous Carcinoma | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585162 |
| 466 | = | B Acute Lymphoblastic Leukemia, BCR-ABL1-Like | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585165 |
| 466 | = | Breast Lobular Carcinoma In Situ | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585161 |
| 466 | = | Early Hepatocellular Carcinoma | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585166 |
| 466 | = | Epithelioid Hemangioendothelioma | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585163 |
| 466 | = | Extraskeletal Ewing Sarcoma | 247 | 83.8 | Medium confidence | pubmed | inputs
ranking row 2585164 |
| 472 | = | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | 246 | 83.6 | Medium confidence | pubmed | inputs
ranking row 2585167 |
| 473 | = | Ocular Melanoma | 244 | 83.6 | Medium confidence | pubmed | inputs
ranking row 2585168 |
| 474 | = | Castration-Sensitive Prostate Carcinoma | 243 | 83.5 | Medium confidence | pubmed | inputs
ranking row 2585170 |
| 474 | = | Embryonal Rhabdomyosarcoma | 243 | 83.5 | Medium confidence | pubmed | inputs
ranking row 2585169 |
| 476 | = | HER2-Positive Gastric Adenocarcinoma | 242 | 83.5 | Medium confidence | pubmed | inputs
ranking row 2585171 |
| 477 | = | Adult Anaplastic Astrocytoma | 241 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2585173 |
| 477 | = | Childhood Anaplastic Astrocytoma | 241 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2585174 |
| 477 | = | Hepatitis B Virus-Related Hepatocellular Carcinoma | 241 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2585175 |
| 477 | = | Myeloid Sarcoma | 241 | 83.4 | Medium confidence | pubmed | inputs
ranking row 2585172 |
| 481 | = | Low-grade Appendiceal Mucinous Neoplasm | 240 | 83.3 | Medium confidence | pubmed | inputs
ranking row 2585176 |
| 482 | = | Pleural Mesothelioma In Situ | 238 | 83.3 | Medium confidence | pubmed | inputs
ranking row 2585177 |
| 483 | = | Appendix Adenocarcinoma | 237 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2585178 |
| 484 | = | Endometrial Endometrioid Adenocarcinoma | 236 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2585181 |
| 484 | = | Hepatoid Adenocarcinoma | 236 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2585180 |
| 484 | = | Malignant Peripheral Nerve Sheath Tumor | 236 | 83.2 | Medium confidence | pubmed | inputs
ranking row 2585179 |
| 487 | = | Gastric Tubular Adenocarcinoma | 231 | 83.1 | Medium confidence | pubmed | inputs
ranking row 2585183 |
| 487 | = | Tubular Adenocarcinoma | 231 | 83.1 | Medium confidence | pubmed | inputs
ranking row 2585182 |
| 489 | = | Gastric Papillary Adenocarcinoma | 229 | 83 | Medium confidence | pubmed | inputs
ranking row 2585184 |
| 490 | = | Well Differentiated Adenocarcinoma | 228 | 83 | Medium confidence | pubmed | inputs
ranking row 2585185 |
| 491 | = | Breast Inflammatory Carcinoma | 227 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2585187 |
| 491 | = | Ovarian Adenocarcinoma | 227 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2585188 |
| 491 | = | Rare Childhood Malignant Neoplasm | 227 | 82.9 | Medium confidence | pubmed | inputs
ranking row 2585186 |
| 494 | = | Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 226 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2585189 |
| 495 | = | Carcinoma ex Pleomorphic Adenoma | 224 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2585190 |
| 496 | = | Brain Embryonal Tumor, Not Otherwise Specified | 223 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2585192 |
| 496 | = | Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive | 223 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2585193 |
| 496 | = | Large Cell Carcinoma | 223 | 82.8 | Medium confidence | pubmed | inputs
ranking row 2585191 |
| 499 | = | Non-Small Cell Carcinoma | 218 | 82.7 | Medium confidence | pubmed | inputs
ranking row 2585194 |
| 500 | = | Nodular Melanoma | 217 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2585195 |
| 500 | = | Non-Clear Cell Renal Cell Carcinoma | 217 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2585196 |
| 502 | = | Intimal Sarcoma | 213 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2585197 |
| 502 | = | Lymphoid Neoplasm | 213 | 82.6 | Medium confidence | pubmed | inputs
ranking row 2585198 |
| 504 | = | Sinonasal Non-Keratinizing Squamous Cell Carcinoma | 212 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2585199 |
| 505 | = | Malignant Hepatobiliary Neoplasm | 210 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2585200 |
| 505 | = | Periampullary Adenocarcinoma | 210 | 82.5 | Medium confidence | pubmed | inputs
ranking row 2585201 |
| 507 | = | Cardiac Lymphoma | 208 | 82.4 | Medium confidence | pubmed | inputs
ranking row 2585203 |
| 507 | = | Malignant Sinonasal Neoplasm | 208 | 82.4 | Medium confidence | pubmed | inputs
ranking row 2585202 |
| 509 | = | Endometrial Serous Adenocarcinoma | 207 | 82.3 | Medium confidence | pubmed | inputs
ranking row 2585205 |
| 509 | = | Metaplastic Carcinoma | 207 | 82.3 | Medium confidence | pubmed | inputs
ranking row 2585204 |
| 511 | = | Grade 3b Follicular Lymphoma | 205 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585206 |
| 512 | = | Adult Desmoplastic Small Round Cell Tumor | 204 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585207 |
| 512 | = | Childhood Desmoplastic Small Round Cell Tumor | 204 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585208 |
| 512 | = | Gallbladder Adenocarcinoma | 204 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585210 |
| 512 | = | Nonmetastatic Castration-Resistant Prostate Carcinoma | 204 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585211 |
| 512 | = | Sinonasal Squamous Cell Carcinoma | 204 | 82.2 | Medium confidence | pubmed | inputs
ranking row 2585209 |
| 517 | = | Sinonasal Carcinoma | 203 | 82 | Medium confidence | pubmed | inputs
ranking row 2585212 |
| 517 | = | Solitary Plasmacytoma | 203 | 82 | Medium confidence | pubmed | inputs
ranking row 2585213 |
| 519 | = | Invasive Lung Mucinous Adenocarcinoma | 202 | 82 | Medium confidence | pubmed | inputs
ranking row 2585214 |
| 520 | = | Pleuropulmonary Blastoma | 201 | 81.9 | Medium confidence | pubmed | inputs
ranking row 2585215 |
| 521 | = | Acute Myeloid Leukemia Post Cytotoxic Therapy | 200 | 81.9 | Medium confidence | pubmed | inputs
ranking row 2585217 |
| 521 | = | Duodenal Adenocarcinoma | 200 | 81.9 | Medium confidence | pubmed | inputs
ranking row 2585218 |
| 521 | = | Malignant Nervous System Neoplasm | 200 | 81.9 | Medium confidence | pubmed | inputs
ranking row 2585216 |
| 524 | = | Adult Erythroleukemia | 199 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2585221 |
| 524 | = | Cardiac Angiosarcoma | 199 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2585219 |
| 524 | = | Erythroleukemia | 199 | 81.8 | Medium confidence | pubmed | inputs
ranking row 2585220 |
| 527 | = | Nodular Lymphocyte Predominant B-Cell Lymphoma | 198 | 81.7 | Medium confidence | pubmed | inputs
ranking row 2585222 |
| 528 | = | Fibrolamellar Carcinoma | 196 | 81.7 | Medium confidence | pubmed | inputs
ranking row 2585223 |
| 528 | = | Lung Small Cell Carcinoma, A Subtype | 196 | 81.7 | Medium confidence | pubmed | inputs
ranking row 2585224 |
| 530 | = | Yolk Sac Tumor | 195 | 81.6 | Medium confidence | pubmed | inputs
ranking row 2585225 |
| 531 | = | Urethral Carcinoma | 194 | 81.5 | Medium confidence | pubmed | inputs
ranking row 2585226 |
| 532 | = | Splenic Marginal Zone Lymphoma | 193 | 81.5 | Medium confidence | pubmed | inputs
ranking row 2585227 |
| 533 | = | Nodular Sclerosis Classic Hodgkin Lymphoma | 192 | 81.5 | Medium confidence | pubmed | inputs
ranking row 2585228 |
| 534 | = | TFE3-Rearranged Renal Cell Carcinoma | 188 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2585229 |
| 535 | = | Adult Acute Monocytic Leukemia | 186 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2585230 |
| 535 | = | Childhood Acute Monocytic Leukemia | 186 | 81.4 | Medium confidence | pubmed | inputs
ranking row 2585231 |
| 537 | = | EBV-Related Gastric Carcinoma | 185 | 81.3 | Medium confidence | pubmed | inputs
ranking row 2585233 |
| 537 | = | Malignant Urinary Tract Neoplasm | 185 | 81.3 | Medium confidence | pubmed | inputs
ranking row 2585232 |
| 539 | = | Lung Large Cell Neuroendocrine Carcinoma | 184 | 81.3 | Medium confidence | pubmed | inputs
ranking row 2585234 |
| 540 | = | Complete Hydatidiform Mole | 183 | 81.2 | Medium confidence | pubmed | inputs
ranking row 2585235 |
| 541 | = | Leukemia Cutis | 182 | 81.2 | Medium confidence | pubmed | inputs
ranking row 2585236 |
| 541 | = | Solid Pseudopapillary Neoplasm of the Pancreas | 182 | 81.2 | Medium confidence | pubmed | inputs
ranking row 2585237 |
| 541 | = | Subcutaneous Panniculitis-Like T-Cell Lymphoma | 182 | 81.2 | Medium confidence | pubmed | inputs
ranking row 2585238 |
| 544 | = | Histiocytic Sarcoma | 181 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2585239 |
| 544 | = | Malignant Duodenal Neoplasm | 181 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2585241 |
| 544 | = | Prostate Intraductal Carcinoma | 181 | 81.1 | Medium confidence | pubmed | inputs
ranking row 2585240 |
| 547 | = | Breast Lymphoma | 180 | 81 | Medium confidence | pubmed | inputs
ranking row 2585242 |
| 547 | = | Childhood Acute Leukemia | 180 | 81 | Medium confidence | pubmed | inputs
ranking row 2585244 |
| 547 | = | Hairy Cell Leukemia | 180 | 81 | Medium confidence | pubmed | inputs
ranking row 2585243 |
| 550 | = | Mixed Germ Cell Tumor | 179 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2585245 |
| 550 | = | T-Cell Large Granular Lymphocyte Leukemia | 179 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2585246 |
| 550 | = | Testicular Seminoma | 179 | 80.9 | Medium confidence | pubmed | inputs
ranking row 2585247 |
| 553 | = | Testicular Mixed Germ Cell Tumor | 178 | 80.8 | Medium confidence | pubmed | inputs
ranking row 2585248 |
| 553 | = | Undifferentiated Pleomorphic Sarcoma | 178 | 80.8 | Medium confidence | pubmed | inputs
ranking row 2585249 |
| 555 | = | Childhood Ganglioneuroblastoma | 177 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2585251 |
| 555 | = | Malignant Eye Neoplasm | 177 | 80.7 | Medium confidence | pubmed | inputs
ranking row 2585250 |
| 557 | = | Endometrioid Stromal Sarcoma | 176 | 80.6 | Medium confidence | pubmed | inputs
ranking row 2585253 |
| 557 | = | Lentigo Maligna | 176 | 80.6 | Medium confidence | pubmed | inputs
ranking row 2585254 |
| 557 | = | Lung Intravascular Large B-Cell Lymphoma | 176 | 80.6 | Medium confidence | pubmed | inputs
ranking row 2585255 |
| 557 | = | Mycosis Fungoides and Sezary Syndrome | 176 | 80.6 | Medium confidence | pubmed | inputs
ranking row 2585256 |
| 557 | = | Ovarian Mixed Germ Cell Tumor | 176 | 80.6 | Medium confidence | pubmed | inputs
ranking row 2585252 |
| 562 | = | Adult Gliosarcoma | 175 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2585257 |
| 562 | = | Childhood Gliosarcoma | 175 | 80.5 | Medium confidence | pubmed | inputs
ranking row 2585258 |
| 564 | = | Adult Nodular Lymphocyte Predominant B-Cell Lymphoma | 174 | 80.4 | Medium confidence | pubmed | inputs
ranking row 2585259 |
| 564 | = | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 174 | 80.4 | Medium confidence | pubmed | inputs
ranking row 2585260 |
| 564 | = | Olfactory Neuroblastoma | 174 | 80.4 | Medium confidence | pubmed | inputs
ranking row 2585261 |
| 567 | = | Malignant Fallopian Tube Neoplasm | 173 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2585262 |
| 567 | = | Skin Angiosarcoma | 173 | 80.3 | Medium confidence | pubmed | inputs
ranking row 2585263 |
| 569 | = | Apocrine Carcinoma | 172 | 80.2 | Medium confidence | pubmed | inputs
ranking row 2585265 |
| 569 | = | Oncocytic Adenocarcinoma | 172 | 80.2 | Medium confidence | pubmed | inputs
ranking row 2585264 |
| 571 | = | Breast Angiosarcoma | 171 | 80.2 | Medium confidence | pubmed | inputs
ranking row 2585267 |
| 571 | = | Kidney Sarcoma | 171 | 80.2 | Medium confidence | pubmed | inputs
ranking row 2585268 |
| 571 | = | Malignant Phyllodes Tumor | 171 | 80.2 | Medium confidence | pubmed | inputs
ranking row 2585266 |
| 574 | = | High Grade Osteosarcoma | 169 | 80 | Medium confidence | pubmed | inputs
ranking row 2585269 |
| 575 | = | Radiation-Related Malignant Neoplasm | 168 | 80 | Medium confidence | pubmed | inputs
ranking row 2585270 |
| 576 | = | T Lymphoblastic Lymphoma | 167 | 80 | Medium confidence | pubmed | inputs
ranking row 2585271 |
| 577 | = | Aggressive Adult Non-Hodgkin Lymphoma | 166 | 79.9 | Medium confidence | pubmed | inputs
ranking row 2585274 |
| 577 | = | Childhood Sarcoma | 166 | 79.9 | Medium confidence | pubmed | inputs
ranking row 2585272 |
| 577 | = | Childhood T Lymphoblastic Lymphoma | 166 | 79.9 | Medium confidence | pubmed | inputs
ranking row 2585273 |
| 580 | = | Adult T Lymphoblastic Lymphoma | 165 | 79.8 | Medium confidence | pubmed | inputs
ranking row 2585277 |
| 580 | = | Early T Precursor Acute Lymphoblastic Leukemia | 165 | 79.8 | Medium confidence | pubmed | inputs
ranking row 2585278 |
| 580 | = | Hereditary Gastric Diffuse Adenocarcinoma | 165 | 79.8 | Medium confidence | pubmed | inputs
ranking row 2585275 |
| 580 | = | Low Grade Endometrioid Stromal Sarcoma | 165 | 79.8 | Medium confidence | pubmed | inputs
ranking row 2585276 |
| 584 | = | Lentigo Maligna Melanoma | 164 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2585281 |
| 584 | = | Obesity-Related Malignant Neoplasm | 164 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2585279 |
| 584 | = | Thyroid Gland Lymphoma | 164 | 79.7 | Medium confidence | pubmed | inputs
ranking row 2585280 |
| 587 | = | Cardiac Sarcoma | 162 | 79.6 | Medium confidence | pubmed | inputs
ranking row 2585282 |
| 588 | = | Anaplastic Large Cell Lymphoma, ALK-Positive | 161 | 79.6 | Medium confidence | pubmed | inputs
ranking row 2585284 |
| 588 | = | Micropapillary Carcinoma | 161 | 79.6 | Medium confidence | pubmed | inputs
ranking row 2585283 |
| 590 | = | Grade 3 Meningioma | 160 | 79.5 | Medium confidence | pubmed | inputs
ranking row 2585285 |
| 590 | = | Low-Grade Serous Ovarian Cancer | 160 | 79.5 | Medium confidence | pubmed | inputs
ranking row 2585286 |
| 592 | = | Ovarian Low Grade Serous Adenocarcinoma | 159 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2585288 |
| 592 | = | Pleomorphic Liposarcoma | 159 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2585287 |
| 594 | = | Breast Periductal Stromal Tumor | 158 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2585289 |
| 594 | = | Intraductal Papillary Neoplasm of the Bile Duct | 158 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2585291 |
| 594 | = | Liver Angiosarcoma | 158 | 79.4 | Medium confidence | pubmed | inputs
ranking row 2585290 |
| 597 | = | Hormone Receptor-Positive Breast Carcinoma | 157 | 79.2 | Medium confidence | pubmed | inputs
ranking row 2585294 |
| 597 | = | Myxoid Liposarcoma | 157 | 79.2 | Medium confidence | pubmed | inputs
ranking row 2585292 |
| 597 | = | Verrucous Carcinoma | 157 | 79.2 | Medium confidence | pubmed | inputs
ranking row 2585293 |
| 600 | = | Infantile Fibrosarcoma | 156 | 79.1 | Medium confidence | pubmed | inputs
ranking row 2585296 |
| 600 | = | Intestinal T-Cell Lymphoma | 156 | 79.1 | Medium confidence | pubmed | inputs
ranking row 2585297 |
| 600 | = | Smoldering Multiple Myeloma | 156 | 79.1 | Medium confidence | pubmed | inputs
ranking row 2585295 |
| 603 | = | Ovarian Endometrioid Adenocarcinoma | 154 | 79 | Medium confidence | pubmed | inputs
ranking row 2585298 |
| 604 | = | Low-CSD Melanoma, Superficial Spreading Melanoma Subtype | 153 | 79 | Medium confidence | pubmed | inputs
ranking row 2585300 |
| 604 | = | Small Intestinal Carcinoma | 153 | 79 | Medium confidence | pubmed | inputs
ranking row 2585299 |
| 606 | = | Ampulla of Vater Adenocarcinoma | 152 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2585301 |
| 607 | = | Glottis Carcinoma | 151 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2585304 |
| 607 | = | Malignant Soft Tissue Neoplasm | 151 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2585302 |
| 607 | = | Papillary Urothelial Carcinoma | 151 | 78.9 | Medium confidence | pubmed | inputs
ranking row 2585303 |
| 610 | = | Adamantinoma-Like Ewing Sarcoma | 150 | 78.8 | Medium confidence | pubmed | inputs
ranking row 2585305 |
| 610 | = | Childhood Malignant Glioma | 150 | 78.8 | Medium confidence | pubmed | inputs
ranking row 2585306 |
| 612 | = | Juvenile Myelomonocytic Leukemia | 149 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585307 |
| 613 | = | Gastric Lymphoma | 147 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585309 |
| 613 | = | Low Grade Fibromyxoid Sarcoma | 147 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585310 |
| 613 | = | Malignant Vascular Neoplasm | 147 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585308 |
| 613 | = | Pleomorphic Carcinoma | 147 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585311 |
| 613 | = | Squamous Cell Carcinoma In Situ | 147 | 78.7 | Medium confidence | pubmed | inputs
ranking row 2585312 |
| 618 | = | Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | 146 | 78.5 | Medium confidence | pubmed | inputs
ranking row 2585315 |
| 618 | = | High Grade Sarcoma | 146 | 78.5 | Medium confidence | pubmed | inputs
ranking row 2585313 |
| 618 | = | Primary Vitreoretinal Non-Hodgkin Lymphoma | 146 | 78.5 | Medium confidence | pubmed | inputs
ranking row 2585314 |
| 621 | = | Fumarate Hydratase-Deficient Renal Cell Carcinoma | 144 | 78.4 | Medium confidence | pubmed | inputs
ranking row 2585317 |
| 621 | = | Pineoblastoma | 144 | 78.4 | Medium confidence | pubmed | inputs
ranking row 2585316 |
| 623 | = | Epithelioid Mesothelioma | 143 | 78.3 | Medium confidence | pubmed | inputs
ranking row 2585318 |
| 623 | = | Mature B-Cell Non-Hodgkin Lymphoma | 143 | 78.3 | Medium confidence | pubmed | inputs
ranking row 2585319 |
| 623 | = | Pancreatic Acinar Cell Carcinoma | 143 | 78.3 | Medium confidence | pubmed | inputs
ranking row 2585320 |
| 626 | = | Childhood Acute Megakaryoblastic Leukemia | 142 | 78.2 | Medium confidence | pubmed | inputs
ranking row 2585321 |
| 627 | = | Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type | 141 | 78.2 | Medium confidence | pubmed | inputs
ranking row 2585324 |
| 627 | = | Malignant Urethral Neoplasm | 141 | 78.2 | Medium confidence | pubmed | inputs
ranking row 2585322 |
| 627 | = | Plasmablastic Lymphoma | 141 | 78.2 | Medium confidence | pubmed | inputs
ranking row 2585323 |
| 630 | = | Adult Acute Megakaryoblastic Leukemia | 139 | 78.1 | Medium confidence | pubmed | inputs
ranking row 2585328 |
| 630 | = | Atypical Lipomatous Tumor | 139 | 78.1 | Medium confidence | pubmed | inputs
ranking row 2585329 |
| 630 | = | Digestive System Lymphoma | 139 | 78.1 | Medium confidence | pubmed | inputs
ranking row 2585325 |
| 630 | = | Malignant Gastrointestinal Neuroectodermal Tumor | 139 | 78.1 | Medium confidence | pubmed | inputs
ranking row 2585326 |
| 630 | = | Melanoma with BRAF Mutation | 139 | 78.1 | Medium confidence | pubmed | inputs
ranking row 2585327 |
| 635 | = | Low Grade Myofibroblastic Sarcoma | 138 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2585330 |
| 635 | = | Malignant Adrenal Gland Neoplasm | 138 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2585331 |
| 637 | = | Acute Leukemia of Ambiguous Lineage | 137 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2585333 |
| 637 | = | Childhood Malignant Solid Neoplasm | 137 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2585332 |
| 637 | = | Gestational Choriocarcinoma | 137 | 77.9 | Medium confidence | pubmed | inputs
ranking row 2585334 |
| 640 | = | Adenocarcinoma In Situ | 136 | 77.8 | Medium confidence | pubmed | inputs
ranking row 2585335 |
| 640 | = | Liver Sarcoma | 136 | 77.8 | Medium confidence | pubmed | inputs
ranking row 2585336 |
| 642 | = | Lung Lymphoma | 135 | 77.7 | Medium confidence | pubmed | inputs
ranking row 2585337 |
| 642 | = | Sebaceous Carcinoma | 135 | 77.7 | Medium confidence | pubmed | inputs
ranking row 2585338 |
| 642 | = | Skull Base Chordoma | 135 | 77.7 | Medium confidence | pubmed | inputs
ranking row 2585339 |
| 645 | = | Anaplastic Large Cell Lymphoma, ALK-Negative | 134 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2585341 |
| 645 | = | Occupational Malignant Neoplasm | 134 | 77.6 | Medium confidence | pubmed | inputs
ranking row 2585340 |
| 647 | = | Adult Primary Cutaneous Anaplastic Large Cell Lymphoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585344 |
| 647 | = | Alveolar Rhabdomyosarcoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585345 |
| 647 | = | Follicular Dendritic Cell Sarcoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585342 |
| 647 | = | Head and Neck Cutaneous Squamous Cell Carcinoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585346 |
| 647 | = | Intestinal Lymphoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585343 |
| 647 | = | Mesonephric-Like Adenocarcinoma | 133 | 77.5 | Medium confidence | pubmed | inputs
ranking row 2585347 |
| 653 | = | Aggressive B-Cell Non-Hodgkin Lymphoma | 131 | 77.3 | Medium confidence | pubmed | inputs
ranking row 2585348 |
| 653 | = | Myelodysplastic Syndrome Post Cytotoxic Therapy | 131 | 77.3 | Medium confidence | pubmed | inputs
ranking row 2585349 |
| 653 | = | Pleomorphic Dermal Sarcoma | 131 | 77.3 | Medium confidence | pubmed | inputs
ranking row 2585350 |
| 653 | = | Primary Intraocular Non-Hodgkin Lymphoma | 131 | 77.3 | Medium confidence | pubmed | inputs
ranking row 2585351 |
| 657 | = | Bone Mesenchymal Chondrosarcoma | 130 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2585352 |
| 657 | = | Childhood Mesenchymal Chondrosarcoma | 130 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2585355 |
| 657 | = | Extraskeletal Myxoid Chondrosarcoma | 130 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2585353 |
| 657 | = | High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements | 130 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2585356 |
| 657 | = | Intestinal-Type Adenocarcinoma | 130 | 77.2 | Medium confidence | pubmed | inputs
ranking row 2585354 |
| 662 | = | Cecum Carcinoma | 129 | 77 | Medium confidence | pubmed | inputs
ranking row 2585357 |
| 663 | = | Central Nervous System Leukemia | 128 | 76.9 | Medium confidence | pubmed | inputs
ranking row 2585359 |
| 663 | = | Epithelial-Myoepithelial Carcinoma | 128 | 76.9 | Medium confidence | pubmed | inputs
ranking row 2585358 |
| 665 | = | Extranodal Non-Hodgkin Lymphoma | 127 | 76.9 | Medium confidence | pubmed | inputs
ranking row 2585360 |
| 666 | = | Indolent Adult Non-Hodgkin Lymphoma | 126 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585361 |
| 667 | = | Bowen Disease of the Skin | 125 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585365 |
| 667 | = | Clear Cell Sarcoma of Soft Tissue | 125 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585362 |
| 667 | = | Goblet Cell Adenocarcinoma | 125 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585363 |
| 667 | = | Myxoid Chondrosarcoma | 125 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585366 |
| 667 | = | Renal Pelvis Carcinoma | 125 | 76.8 | Medium confidence | pubmed | inputs
ranking row 2585364 |
| 672 | = | Acute Myeloid Leukemia, Myelodysplasia-Related | 124 | 76.6 | Medium confidence | pubmed | inputs
ranking row 2585368 |
| 672 | = | Childhood Lymphoma | 124 | 76.6 | Medium confidence | pubmed | inputs
ranking row 2585367 |
| 672 | = | Collecting Duct Carcinoma | 124 | 76.6 | Medium confidence | pubmed | inputs
ranking row 2585369 |
| 675 | = | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 123 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2585372 |
| 675 | = | MSI-H Colorectal Carcinoma | 123 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2585374 |
| 675 | = | Myxoinflammatory Fibroblastic Sarcoma | 123 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2585370 |
| 675 | = | Orbital Lymphoma | 123 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2585371 |
| 675 | = | Uterine Corpus High Grade Endometrial Stromal Sarcoma | 123 | 76.5 | Medium confidence | pubmed | inputs
ranking row 2585373 |
| 680 | = | Anorectal Melanoma | 122 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2585375 |
| 680 | = | Clivus Chordoma | 122 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2585377 |
| 680 | = | Malignant Lip Neoplasm | 122 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2585376 |
| 680 | = | Tonsillar Carcinoma | 122 | 76.4 | Medium confidence | pubmed | inputs
ranking row 2585378 |
| 684 | = | Alveolar Soft Part Sarcoma | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585381 |
| 684 | = | Core Binding Factor Acute Myeloid Leukemia | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585384 |
| 684 | = | Digestive System Mixed Adenoneuroendocrine Carcinoma | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585379 |
| 684 | = | Hyalinizing Clear Cell Carcinoma | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585380 |
| 684 | = | Plasma Cell Myeloma-Induced Bone Disease | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585382 |
| 684 | = | Sacral Chordoma | 121 | 76.2 | Medium confidence | pubmed | inputs
ranking row 2585383 |
| 690 | = | Adult-Type Diffuse Glioma | 120 | 76 | Medium confidence | pubmed | inputs
ranking row 2585386 |
| 690 | = | Myeloid Leukemia Associated with Down Syndrome | 120 | 76 | Medium confidence | pubmed | inputs
ranking row 2585385 |
| 692 | = | Extranodal NK-/T-Cell Lymphoma, Nasal Type | 119 | 75.9 | Medium confidence | pubmed | inputs
ranking row 2585388 |
| 692 | = | Malignant Odontogenic Neoplasm | 119 | 75.9 | Medium confidence | pubmed | inputs
ranking row 2585387 |
| 694 | = | Myelodysplastic Syndrome with Excess Blasts | 118 | 75.9 | Medium confidence | pubmed | inputs
ranking row 2585390 |
| 694 | = | Transient Abnormal Myelopoiesis Associated with Down Syndrome | 118 | 75.9 | Medium confidence | pubmed | inputs
ranking row 2585389 |
| 696 | = | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | 117 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2585391 |
| 697 | = | Ovarian Serous Cystadenocarcinoma | 116 | 75.8 | Medium confidence | pubmed | inputs
ranking row 2585392 |
| 698 | = | Liver Epithelioid Hemangioendothelioma | 115 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585394 |
| 698 | = | Thoracic SMARCA4-Deficient Undifferentiated Tumor | 115 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585393 |
| 700 | = | Keratinizing Squamous Cell Carcinoma | 114 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585396 |
| 700 | = | Lung Keratinizing Squamous Cell Carcinoma | 114 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585398 |
| 700 | = | Lung Small Cell Carcinoma, N Subtype | 114 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585399 |
| 700 | = | Plasma Cell Leukemia | 114 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585395 |
| 700 | = | Primary Effusion Lymphoma | 114 | 75.7 | Medium confidence | pubmed | inputs
ranking row 2585397 |
| 705 | = | Ameloblastic Carcinoma | 113 | 75.5 | Medium confidence | pubmed | inputs
ranking row 2585400 |
| 705 | = | Lip Squamous Cell Carcinoma | 113 | 75.5 | Medium confidence | pubmed | inputs
ranking row 2585401 |
| 707 | = | Acute Erythroid Leukemia | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585403 |
| 707 | = | Breast Sarcoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585402 |
| 707 | = | Extraskeletal Osteosarcoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585404 |
| 707 | = | Invasive Bladder Carcinoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585405 |
| 707 | = | Liver Embryonal Sarcoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585407 |
| 707 | = | Pancreatic Neuroendocrine Carcinoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585406 |
| 707 | = | Pituitary Carcinoma | 112 | 75.4 | Medium confidence | pubmed | inputs
ranking row 2585408 |
| 714 | = | Tonsillar Squamous Cell Carcinoma | 111 | 75.2 | Medium confidence | pubmed | inputs
ranking row 2585409 |
| 715 | = | Basaloid Squamous Cell Carcinoma | 110 | 75.1 | Medium confidence | pubmed | inputs
ranking row 2585410 |
| 715 | = | Mediastinal Lymphoma | 110 | 75.1 | Medium confidence | pubmed | inputs
ranking row 2585411 |
| 717 | = | Gliomatosis Cerebri | 109 | 75.1 | Medium confidence | pubmed | inputs
ranking row 2585413 |
| 717 | = | Sinonasal Mucosal Melanoma | 109 | 75.1 | Medium confidence | pubmed | inputs
ranking row 2585412 |
| 719 | = | Desmoplastic Melanoma | 108 | 75 | Medium confidence | pubmed | inputs
ranking row 2585414 |
| 719 | = | High-Grade Endometrial Stromal Sarcoma | 108 | 75 | Medium confidence | pubmed | inputs
ranking row 2585416 |
| 719 | = | Sarcomatoid Renal Cell Carcinoma | 108 | 75 | Medium confidence | pubmed | inputs
ranking row 2585415 |
| 722 | = | Adult T Acute Lymphoblastic Leukemia | 107 | 74.9 | Medium confidence | pubmed | inputs
ranking row 2585417 |
| 722 | = | Lung Small Cell Carcinoma, P Subtype | 107 | 74.9 | Medium confidence | pubmed | inputs
ranking row 2585419 |
| 722 | = | Subungual Melanoma | 107 | 74.9 | Medium confidence | pubmed | inputs
ranking row 2585418 |
| 725 | = | Clear Cell Sarcoma of the Kidney | 106 | 74.8 | Medium confidence | pubmed | inputs
ranking row 2585421 |
| 725 | = | Lung Melanoma | 106 | 74.8 | Medium confidence | pubmed | inputs
ranking row 2585420 |
| 725 | = | Medulloblastoma, WNT-Activated | 106 | 74.8 | Medium confidence | pubmed | inputs
ranking row 2585422 |
| 725 | = | Pulmonary Blastoma | 106 | 74.8 | Medium confidence | pubmed | inputs
ranking row 2585423 |
| 725 | = | Sinonasal Undifferentiated Carcinoma | 106 | 74.8 | Medium confidence | pubmed | inputs
ranking row 2585424 |
| 730 | = | Dedifferentiated Chondrosarcoma | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585425 |
| 730 | = | Malignant Uterine Corpus Neoplasm | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585428 |
| 730 | = | Ovarian Small Cell Carcinoma | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585426 |
| 730 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585429 |
| 730 | = | Transient Abnormal Myelopoiesis | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585430 |
| 730 | = | Ureter Carcinoma | 105 | 74.6 | Medium confidence | pubmed | inputs
ranking row 2585427 |
| 736 | = | Urachal Carcinoma | 104 | 74.4 | Medium confidence | pubmed | inputs
ranking row 2585431 |
| 737 | = | Adult Extraskeletal Osteosarcoma | 103 | 74.4 | Medium confidence | pubmed | inputs
ranking row 2585433 |
| 737 | = | Sweat Gland Carcinoma | 103 | 74.4 | Medium confidence | pubmed | inputs
ranking row 2585432 |
| 739 | = | Amelanotic Melanoma | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585434 |
| 739 | = | Kidney Medullary Carcinoma | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585436 |
| 739 | = | Parathyroid Cancer | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585437 |
| 739 | = | Partial Hydatidiform Mole | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585439 |
| 739 | = | Renal Medullary Carcinoma | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585438 |
| 739 | = | Serous Adenocarcinoma | 102 | 74.3 | Medium confidence | pubmed | inputs
ranking row 2585435 |
| 745 | = | Biliary Tract Carcinoma | 101 | 74.1 | Medium confidence | pubmed | inputs
ranking row 2585441 |
| 745 | = | Malignant Germ Cell Tumor | 101 | 74.1 | Medium confidence | pubmed | inputs
ranking row 2585440 |
| 747 | = | Adult Extraskeletal Myxoid Chondrosarcoma | 100 | 74 | Medium confidence | pubmed | inputs
ranking row 2585443 |
| 747 | = | Anaplastic (Malignant) Meningioma | 100 | 74 | Medium confidence | pubmed | inputs
ranking row 2585442 |
| 749 | = | Chronic Eosinophilic Leukemia, Not Otherwise Specified | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585444 |
| 749 | = | Cutaneous Merkel Cell Carcinoma | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585445 |
| 749 | = | Follicular Variant Thyroid Gland Papillary Carcinoma | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585449 |
| 749 | = | Platinum-Sensitive Ovarian Carcinoma | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585448 |
| 749 | = | Prolymphocytic Leukemia | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585446 |
| 749 | = | Sclerosing Epithelioid Fibrosarcoma | 98 | 74 | Medium confidence | pubmed | inputs
ranking row 2585447 |
| 755 | = | CIC-Rearranged Sarcoma | 97 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2585450 |
| 756 | = | Breast Mucinous Carcinoma | 96 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2585452 |
| 756 | = | dMMR Colorectal Carcinoma | 96 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2585454 |
| 756 | = | Ocular Adnexal Non-Hodgkin Lymphoma | 96 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2585451 |
| 756 | = | Pancreatoblastoma | 96 | 73.7 | Medium confidence | pubmed | inputs
ranking row 2585453 |
| 760 | = | CRTC1-TRIM11 Cutaneous Tumor | 95 | 73.6 | Medium confidence | pubmed | inputs
ranking row 2585455 |
| 760 | = | Desmoplastic Small Round Cell Tumor | 95 | 73.6 | Medium confidence | pubmed | inputs
ranking row 2585457 |
| 760 | = | Granulocytic Sarcoma | 95 | 73.6 | Medium confidence | pubmed | inputs
ranking row 2585456 |
| 760 | = | Liver Lymphoma | 95 | 73.6 | Medium confidence | pubmed | inputs
ranking row 2585458 |
| 764 | = | Gastric Carcinoma with Lymphoid Stroma | 94 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585460 |
| 764 | = | Hereditary Melanoma | 94 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585459 |
| 766 | = | Childhood Intraocular Retinoblastoma | 93 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585464 |
| 766 | = | Choroid Plexus Carcinoma | 93 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585461 |
| 766 | = | Intraocular Retinoblastoma | 93 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585465 |
| 766 | = | Lung Sarcoma | 93 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585462 |
| 766 | = | Odontogenic Carcinoma | 93 | 73.4 | Medium confidence | pubmed | inputs
ranking row 2585463 |
| 771 | = | Acute Megakaryoblastic Leukemia | 92 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2585467 |
| 771 | = | Embryonal Tumor with Multilayered Rosettes | 92 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2585466 |
| 771 | = | Liver Neuroendocrine Carcinoma | 92 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2585468 |
| 771 | = | Testicular Lymphoma | 92 | 73.2 | Medium confidence | pubmed | inputs
ranking row 2585469 |
| 775 | = | Chronic Leukemia | 91 | 73.1 | Medium confidence | pubmed | inputs
ranking row 2585470 |
| 775 | = | Endolymphatic Sac Tumor | 91 | 73.1 | Medium confidence | pubmed | inputs
ranking row 2585472 |
| 775 | = | Iris Melanoma | 91 | 73.1 | Medium confidence | pubmed | inputs
ranking row 2585471 |
| 778 | = | Anaplastic Ependymoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585473 |
| 778 | = | Hepatosplenic T-Cell Lymphoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585476 |
| 778 | = | Mesonephric Adenocarcinoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585477 |
| 778 | = | Pediatric-Type Follicular Lymphoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585479 |
| 778 | = | Primary Cutaneous Follicle Center Lymphoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585478 |
| 778 | = | Sarcoma of the Extremity | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585474 |
| 778 | = | Splenic Angiosarcoma | 90 | 72.9 | Medium confidence | pubmed | inputs
ranking row 2585475 |
| 785 | = | Folliculotropic Mycosis Fungoides | 89 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2585480 |
| 785 | = | Polymorphous Adenocarcinoma | 89 | 72.7 | Medium confidence | pubmed | inputs
ranking row 2585481 |
| 787 | = | Adult Anaplastic Ependymoma | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585484 |
| 787 | = | Anaplastic Oligodendroglioma | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585482 |
| 787 | = | Breast Papillary Carcinoma | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585483 |
| 787 | = | Childhood Anaplastic Ependymoma | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585485 |
| 787 | = | Childhood T Acute Lymphoblastic Leukemia | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585486 |
| 787 | = | Cytogenetically Normal Acute Myeloid Leukemia | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585487 |
| 787 | = | Muscle Invasive Bladder Carcinoma | 88 | 72.6 | Medium confidence | pubmed | inputs
ranking row 2585488 |
| 794 | = | Infant Acute Lymphoblastic Leukemia | 87 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2585490 |
| 794 | = | T Lymphoblastic Leukemia/Lymphoma | 87 | 72.4 | Medium confidence | pubmed | inputs
ranking row 2585489 |
| 796 | = | Adult Anaplastic Oligodendroglioma | 86 | 72.3 | Medium confidence | pubmed | inputs
ranking row 2585491 |
| 796 | = | Childhood Anaplastic Oligodendroglioma | 86 | 72.3 | Medium confidence | pubmed | inputs
ranking row 2585492 |
| 796 | = | Fallopian Tube Carcinoma | 86 | 72.3 | Medium confidence | pubmed | inputs
ranking row 2585494 |
| 796 | = | Thyroid Carcinoma Arising in Struma Ovarii | 86 | 72.3 | Medium confidence | pubmed | inputs
ranking row 2585493 |
| 800 | = | Aggressive NK-Cell Leukemia | 85 | 72.2 | Medium confidence | pubmed | inputs
ranking row 2585497 |
| 800 | = | Malignant Solitary Fibrous Tumor | 85 | 72.2 | Medium confidence | pubmed | inputs
ranking row 2585495 |
| 800 | = | Skin Sarcoma | 85 | 72.2 | Medium confidence | pubmed | inputs
ranking row 2585496 |
| 800 | = | Small Intestinal Lymphoma | 85 | 72.2 | Medium confidence | pubmed | inputs
ranking row 2585498 |
| 804 | = | Glottic Squamous Cell Carcinoma | 83 | 72 | Medium confidence | pubmed | inputs
ranking row 2585500 |
| 804 | = | Squamous Cell Carcinoma of Unknown Primary | 83 | 72 | Medium confidence | pubmed | inputs
ranking row 2585499 |
| 806 | = | B Lymphoblastic Lymphoma | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585502 |
| 806 | = | Cutaneous Spitz Melanoma | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585503 |
| 806 | = | Lymphangitic Carcinomatosis | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585506 |
| 806 | = | Melanoma of Unknown Primary | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585504 |
| 806 | = | Non-Seminomatous Germ Cell Tumor | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585508 |
| 806 | = | Primary Bone Lymphoma | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585505 |
| 806 | = | Superficial Basal Cell Carcinoma | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585507 |
| 806 | = | Vulvar Melanoma | 82 | 72 | Medium confidence | pubmed | inputs
ranking row 2585501 |
| 814 | = | Acute Myeloid Leukemia with NPM1 Mutation | 81 | 71.7 | Medium confidence | pubmed | inputs
ranking row 2585510 |
| 814 | = | Hereditary Melanoma with CDKN2A Mutation | 81 | 71.7 | Medium confidence | pubmed | inputs
ranking row 2585509 |
| 814 | = | Proximal Colon Carcinoma | 81 | 71.7 | Medium confidence | pubmed | inputs
ranking row 2585511 |
| 817 | = | Bladder Adenocarcinoma | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585515 |
| 817 | = | Duodenal Carcinoma | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585516 |
| 817 | = | Inferior Vena Cava Leiomyosarcoma | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585517 |
| 817 | = | Ovarian Carcinosarcoma | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585512 |
| 817 | = | Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585513 |
| 817 | = | Prostate Acinar Adenocarcinoma | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585514 |
| 817 | = | Testicular Germ Cell Neoplasia In Situ | 80 | 71.6 | Medium confidence | pubmed | inputs
ranking row 2585518 |
| 824 | = | Biphenotypic Sinonasal Sarcoma | 79 | 71.3 | Medium confidence | pubmed | inputs
ranking row 2585519 |
| 824 | = | Childhood Pleomorphic Rhabdomyosarcoma | 79 | 71.3 | Medium confidence | pubmed | inputs
ranking row 2585521 |
| 824 | = | Malignant Rectosigmoid Neoplasm | 79 | 71.3 | Medium confidence | pubmed | inputs
ranking row 2585522 |
| 824 | = | Nodal Marginal Zone Lymphoma | 79 | 71.3 | Medium confidence | pubmed | inputs
ranking row 2585523 |
| 824 | = | Pleomorphic Rhabdomyosarcoma | 79 | 71.3 | Medium confidence | pubmed | inputs
ranking row 2585520 |
| 829 | = | Combined Lung Small Cell Carcinoma | 78 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2585526 |
| 829 | = | Conjunctival Squamous Cell Carcinoma | 78 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2585525 |
| 829 | = | Primary Peritoneal Carcinoma | 78 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2585524 |
| 829 | = | T-Cell Prolymphocytic Leukemia | 78 | 71.2 | Medium confidence | pubmed | inputs
ranking row 2585527 |
| 833 | = | Acute Biphenotypic Leukemia | 77 | 71 | Medium confidence | pubmed | inputs
ranking row 2585528 |
| 833 | = | Ovarian Small Cell Carcinoma, Hypercalcemic Type | 77 | 71 | Medium confidence | pubmed | inputs
ranking row 2585529 |
| 833 | = | Undifferentiated Embryonal Sarcoma of the Liver | 77 | 71 | Medium confidence | pubmed | inputs
ranking row 2585530 |
| 836 | = | Gastric Neuroendocrine Carcinoma | 76 | 70.9 | Medium confidence | pubmed | inputs
ranking row 2585531 |
| 836 | = | Hairy Cell Leukemia Variant | 76 | 70.9 | Medium confidence | pubmed | inputs
ranking row 2585532 |
| 836 | = | Hepatopancreatobiliary Carcinoma | 76 | 70.9 | Medium confidence | pubmed | inputs
ranking row 2585533 |
| 836 | = | Microcystic Adnexal Carcinoma | 76 | 70.9 | Medium confidence | pubmed | inputs
ranking row 2585534 |
| 840 | = | Eosinophilic Solid and Cystic Renal Cell Carcinoma | 75 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2585537 |
| 840 | = | Infant T Acute Lymphoblastic Leukemia | 75 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2585536 |
| 840 | = | Meningeal Melanoma | 75 | 70.8 | Medium confidence | pubmed | inputs
ranking row 2585535 |
| 843 | = | Incidental Gallbladder Carcinoma | 74 | 70.7 | Medium confidence | pubmed | inputs
ranking row 2585540 |
| 843 | = | Spinal Chordoma | 74 | 70.7 | Medium confidence | pubmed | inputs
ranking row 2585539 |
| 843 | = | Splenic Lymphoma | 74 | 70.7 | Medium confidence | pubmed | inputs
ranking row 2585538 |
| 843 | = | Urachal Adenocarcinoma | 74 | 70.7 | Medium confidence | pubmed | inputs
ranking row 2585541 |
| 847 | = | Adult B Lymphoblastic Lymphoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585546 |
| 847 | = | Childhood B Lymphoblastic Lymphoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585542 |
| 847 | = | EBV-Related Nasopharyngeal Squamous Cell Carcinoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585547 |
| 847 | = | Eyelid Carcinoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585548 |
| 847 | = | Ganglioneuroblastoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585543 |
| 847 | = | Hidradenocarcinoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585549 |
| 847 | = | Kidney Non-Hodgkin Lymphoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585544 |
| 847 | = | Malignant Intracranial Neoplasm | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585545 |
| 847 | = | Spindle Cell Rhabdomyosarcoma | 73 | 70.5 | Medium confidence | pubmed | inputs
ranking row 2585550 |
| 856 | = | Lepidic Adenocarcinoma | 72 | 70.2 | Medium confidence | pubmed | inputs
ranking row 2585553 |
| 856 | = | Myeloid Neoplasm Post Cytotoxic Therapy | 72 | 70.2 | Medium confidence | pubmed | inputs
ranking row 2585551 |
| 856 | = | Rhabdoid Tumor of the Kidney | 72 | 70.2 | Medium confidence | pubmed | inputs
ranking row 2585552 |
| 859 | = | Malignant PEComa | 71 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585554 |
| 859 | = | Tracheal Adenoid Cystic Carcinoma | 71 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585555 |
| 861 | = | Childhood Malignant Liver Neoplasm | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585557 |
| 861 | = | Digital Papillary Adenocarcinoma | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585558 |
| 861 | = | Low Grade Sarcoma | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585556 |
| 861 | = | Monophasic Synovial Sarcoma | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585559 |
| 861 | = | Porocarcinoma | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585561 |
| 861 | = | Uterine Corpus Undifferentiated Sarcoma | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585560 |
| 861 | = | Vulvar Paget Disease | 70 | 70.1 | Medium confidence | pubmed | inputs
ranking row 2585562 |
| 868 | = | Breast Melanoma | 69 | 69.8 | Medium confidence | pubmed | inputs
ranking row 2585563 |
| 868 | = | Central Nervous System Medulloepithelioma | 69 | 69.8 | Medium confidence | pubmed | inputs
ranking row 2585564 |
| 868 | = | Double-Expressor Lymphoma | 69 | 69.8 | Medium confidence | pubmed | inputs
ranking row 2585566 |
| 868 | = | Secondary Central Nervous System Lymphoma | 69 | 69.8 | Medium confidence | pubmed | inputs
ranking row 2585565 |
| 872 | = | Appendix Carcinoma | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585568 |
| 872 | = | Early Stage Endometrial Carcinoma | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585572 |
| 872 | = | Gastric Adenocarcinoma of Fundic-Gland Type | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585574 |
| 872 | = | Lung Mucosa-Associated Lymphoid Tissue Lymphoma | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585569 |
| 872 | = | Malignant Parotid Gland Neoplasm | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585571 |
| 872 | = | Prefibrotic Primary Myelofibrosis | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585573 |
| 872 | = | Systemic Mastocytosis with an Associated Myeloid Neoplasm | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585570 |
| 872 | = | Treatment-Related Prostate Neuroendocrine Carcinoma | 68 | 69.7 | Medium confidence | pubmed | inputs
ranking row 2585567 |
| 880 | = | Distal Colon Carcinoma | 67 | 69.4 | Medium confidence | pubmed | inputs
ranking row 2585579 |
| 880 | = | Embryonal Tumor with Multilayered Rosettes, C19MC-Altered | 67 | 69.4 | Medium confidence | pubmed | inputs
ranking row 2585576 |
| 880 | = | Malignant Tonsillar Neoplasm | 67 | 69.4 | Medium confidence | pubmed | inputs
ranking row 2585577 |
| 880 | = | Medulloblastoma, SHH-Activated | 67 | 69.4 | Medium confidence | pubmed | inputs
ranking row 2585578 |
| 880 | = | Small Cell Sarcoma | 67 | 69.4 | Medium confidence | pubmed | inputs
ranking row 2585575 |
| 885 | = | Gastric AFP-Producing Adenocarcinoma | 66 | 69.2 | Medium confidence | pubmed | inputs
ranking row 2585582 |
| 885 | = | Malignant Extrahepatic Bile Duct Neoplasm | 66 | 69.2 | Medium confidence | pubmed | inputs
ranking row 2585580 |
| 885 | = | Skin Nodular Basal Cell Carcinoma | 66 | 69.2 | Medium confidence | pubmed | inputs
ranking row 2585581 |
| 888 | = | High Grade Appendix Mucinous Neoplasm | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585586 |
| 888 | = | Lip Carcinoma | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585587 |
| 888 | = | Malignant Mixed Mesodermal (Mullerian) Tumor | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585584 |
| 888 | = | Pelvic Sarcoma | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585585 |
| 888 | = | Somatic-Type Malignancy | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585583 |
| 888 | = | Urinary Tract Carcinoma | 65 | 69.1 | Medium confidence | pubmed | inputs
ranking row 2585588 |
| 894 | = | Adult Systemic Anaplastic Large Cell Lymphoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585592 |
| 894 | = | AIDS-Related Lymphoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585590 |
| 894 | = | B Lymphoblastic Leukemia/Lymphoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585589 |
| 894 | = | Epithelioid Glioblastoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585593 |
| 894 | = | Lacrimal Gland Adenoid Cystic Carcinoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585594 |
| 894 | = | Sinonasal Adenocarcinoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585595 |
| 894 | = | Systemic Anaplastic Large Cell Lymphoma | 64 | 68.9 | Medium confidence | pubmed | inputs
ranking row 2585591 |
| 901 | = | Chondroblastic Osteosarcoma | 63 | 68.7 | Medium confidence | pubmed | inputs
ranking row 2585599 |
| 901 | = | Lung Adenosquamous Carcinoma | 63 | 68.7 | Medium confidence | pubmed | inputs
ranking row 2585597 |
| 901 | = | Retroperitoneal Leiomyosarcoma | 63 | 68.7 | Medium confidence | pubmed | inputs
ranking row 2585598 |
| 901 | = | Uterine Corpus Adenosarcoma | 63 | 68.7 | Medium confidence | pubmed | inputs
ranking row 2585596 |
| 905 | = | Acute Monoblastic Leukemia | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585611 |
| 905 | = | Adult Brain Glioblastoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585606 |
| 905 | = | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585607 |
| 905 | = | Brain Glioblastoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585601 |
| 905 | = | Breast Paget Disease | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585608 |
| 905 | = | Childhood Brain Glioblastoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585609 |
| 905 | = | Lung Non-Keratinizing Squamous Cell Carcinoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585610 |
| 905 | = | Malignant Breast Phyllodes Tumor | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585600 |
| 905 | = | Mesenchymal Chondrosarcoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585602 |
| 905 | = | Non-Keratinizing Squamous Cell Carcinoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585603 |
| 905 | = | Pancreatic Lymphoma | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585604 |
| 905 | = | Urothelial Carcinoma In Situ | 62 | 68.5 | Medium confidence | pubmed | inputs
ranking row 2585605 |
| 917 | = | Cecum Adenocarcinoma | 61 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2585615 |
| 917 | = | Gastroesophageal Junction Carcinoma | 61 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2585614 |
| 917 | = | Head and Neck Mucosal Melanoma | 61 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2585612 |
| 917 | = | Malignant Superior Sulcus Neoplasm | 61 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2585613 |
| 917 | = | Sigmoid Colon Adenocarcinoma | 61 | 68.1 | Medium confidence | pubmed | inputs
ranking row 2585616 |
| 922 | = | Adult Acute Erythroid Leukemia | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585618 |
| 922 | = | B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585621 |
| 922 | = | Childhood Acute Erythroid Leukemia | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585619 |
| 922 | = | Gray-Zone Lymphoma | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585620 |
| 922 | = | Head and Neck Sarcoma | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585617 |
| 922 | = | Posttransplant Lymphoproliferative Disorders | 60 | 67.9 | Medium confidence | pubmed | inputs
ranking row 2585622 |
| 928 | = | Adenosarcoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585623 |
| 928 | = | Bladder Squamous Cell Carcinoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585628 |
| 928 | = | Dysgerminoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585624 |
| 928 | = | Esophageal Neuroendocrine Carcinoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585625 |
| 928 | = | Follicular Helper T-Cell Lymphoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585631 |
| 928 | = | Hormone Receptor and HER2 Co-Expressing Breast Carcinoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585629 |
| 928 | = | Intramucosal Adenocarcinoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585626 |
| 928 | = | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585630 |
| 928 | = | Sinonasal Sarcoma | 59 | 67.7 | Medium confidence | pubmed | inputs
ranking row 2585627 |
| 937 | = | Adult Acute Myelomonocytic Leukemia | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585637 |
| 937 | = | Cerebral Lymphoma | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585633 |
| 937 | = | Childhood Acute Myelomonocytic Leukemia | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585638 |
| 937 | = | Esophageal Melanoma | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585634 |
| 937 | = | Hereditary Ovarian Carcinoma | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585632 |
| 937 | = | Malignant Anorectal Neoplasm | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585636 |
| 937 | = | Malignant Small Intestinal Neoplasm | 58 | 67.4 | Medium confidence | pubmed | inputs
ranking row 2585635 |
| 944 | = | Chondrosarcoma, Grade 3 | 57 | 67.2 | Medium confidence | pubmed | inputs
ranking row 2585639 |
| 944 | = | Gingival Carcinoma | 57 | 67.2 | Medium confidence | pubmed | inputs
ranking row 2585640 |
| 944 | = | Sarcomatosis | 57 | 67.2 | Medium confidence | pubmed | inputs
ranking row 2585641 |
| 944 | = | Squamoid Eccrine Ductal Carcinoma | 57 | 67.2 | Medium confidence | pubmed | inputs
ranking row 2585642 |
| 948 | = | Adrenal Gland Neuroblastoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585650 |
| 948 | = | Appendix Mucinous Adenocarcinoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585645 |
| 948 | = | Brain Sarcoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585646 |
| 948 | = | Gingival Squamous Cell Carcinoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585651 |
| 948 | = | Head and Neck Adenoid Cystic Carcinoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585644 |
| 948 | = | High Grade B-Cell Lymphoma with MYC, BCL2, and BCL6 Rearrangements | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585653 |
| 948 | = | Hyperdiploid B Lymphoblastic Leukemia/Lymphoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585647 |
| 948 | = | Neuroblastic Tumor | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585643 |
| 948 | = | Primary Breast Angiosarcoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585648 |
| 948 | = | Primary Cutaneous Gamma-Delta T-Cell Lymphoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585649 |
| 948 | = | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | 56 | 67 | Medium confidence | pubmed | inputs
ranking row 2585652 |
| 959 | = | Bone Osteosarcoma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585656 |
| 959 | = | Hepatocellular Macrotrabecular Massive Carcinoma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585659 |
| 959 | = | Malignant Tracheal Neoplasm | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585654 |
| 959 | = | Mucinous Cystadenocarcinoma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585655 |
| 959 | = | Myeloproliferative Neoplasm, Not Otherwise Specified | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585657 |
| 959 | = | Orbital Rhabdomyosarcoma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585660 |
| 959 | = | Thymus Squamous Cell Carcinoma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585658 |
| 959 | = | WHO Grade 3 Glioma | 55 | 66.6 | Medium confidence | pubmed | inputs
ranking row 2585661 |
| 967 | = | Cervical Invasive Stratified Mucinous Adenocarcinoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585666 |
| 967 | = | Colon Lymphoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585667 |
| 967 | = | Gastric Cardia Adenocarcinoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585668 |
| 967 | = | Invasive Conventional Urothelial Carcinoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585663 |
| 967 | = | Malignant Cardiac Neoplasm | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585662 |
| 967 | = | Salivary Gland Adenoid Cystic Carcinoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585664 |
| 967 | = | Throat Carcinoma | 54 | 66.4 | Medium confidence | pubmed | inputs
ranking row 2585665 |
| 974 | = | Adult Lymphoma | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585669 |
| 974 | = | Anal Melanoma | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585671 |
| 974 | = | Classic Kaposi Sarcoma | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585672 |
| 974 | = | Mesothelioma In Situ | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585670 |
| 974 | = | Nail Apparatus Melanoma | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585673 |
| 974 | = | Submandibular Gland Carcinoma | 53 | 66.1 | Medium confidence | pubmed | inputs
ranking row 2585674 |
| 980 | = | Cribriform Carcinoma | 52 | 65.9 | Medium confidence | pubmed | inputs
ranking row 2585675 |
| 980 | = | Diffuse Midline Glioma, H3 K27-Altered | 52 | 65.9 | Medium confidence | pubmed | inputs
ranking row 2585679 |
| 980 | = | Gliosarcoma | 52 | 65.9 | Medium confidence | pubmed | inputs
ranking row 2585677 |
| 980 | = | Neck Squamous Cell Carcinoma of Unknown Primary | 52 | 65.9 | Medium confidence | pubmed | inputs
ranking row 2585678 |
| 980 | = | Spindle Cell Squamous Carcinoma | 52 | 65.9 | Medium confidence | pubmed | inputs
ranking row 2585676 |
| 985 | = | EBV-Related Lymphoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585681 |
| 985 | = | Infant Leukemia | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585682 |
| 985 | = | Mixed Carcinoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585680 |
| 985 | = | Parotid Gland Mucoepidermoid Carcinoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585687 |
| 985 | = | Pilomatrical Carcinoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585684 |
| 985 | = | Round Cell Sarcoma with EWSR1-non-ETS Fusion | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585683 |
| 985 | = | Telangiectatic Osteosarcoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585686 |
| 985 | = | Undifferentiated Round Cell Sarcoma | 51 | 65.7 | Medium confidence | pubmed | inputs
ranking row 2585685 |
| 993 | = | Blastic Plasmacytoid Dendritic Cell Neoplasm | 50 | 65.5 | Medium confidence | pubmed | inputs
ranking row 2585688 |
| 993 | = | EBV-Positive Inflammatory Follicular Dendritic Cell/Fibroblastic Reticular Cell Tumor | 50 | 65.5 | Medium confidence | pubmed | inputs
ranking row 2585689 |
| 993 | = | Gastric Diffuse Large B-Cell Lymphoma | 50 | 65.5 | Medium confidence | pubmed | inputs
ranking row 2585690 |
| 993 | = | Solid Lung Adenocarcinoma | 50 | 65.5 | Medium confidence | pubmed | inputs
ranking row 2585691 |
| 993 | = | Succinate Dehydrogenase-Deficient Renal Cell Carcinoma | 50 | 65.5 | Medium confidence | pubmed | inputs
ranking row 2585692 |
| 998 | = | Early Esophageal Adenocarcinoma | 49 | 65.3 | Medium confidence | pubmed | inputs
ranking row 2585695 |
| 998 | = | Enteropathy-Associated T-Cell Lymphoma | 49 | 65.3 | Medium confidence | pubmed | inputs
ranking row 2585697 |
| 998 | = | External Auditory Canal Squamous Cell Carcinoma | 49 | 65.3 | Medium confidence | pubmed | inputs
ranking row 2585698 |
Data updated 16 hours agoSource updated unknown2,873 eligible entities · inputs hash 531d42217f151c0dd79899a6